DERMATOLOGY

32
ANNUAL REPORT 2003 DERMATOLOGY FOUNDATION Shaping the Future of DERMATOLOGY

Transcript of DERMATOLOGY

Page 1: DERMATOLOGY

ANNUAL REPORT 2003

DERMATOLOGY FOUNDATION

Shaping the Future of

DERMATOLOGY

Page 2: DERMATOLOGY

INSIDEREPORT FROM THE TRUSTEES . . . . . . . . . . . . . . . . . . . 1

RECAPPING 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

04 PHYSICIAN SCIENTIST CAREER DEVELOPMENT AWARDS . . . . . . . . . . . . . . . . . . . . . . 4

04 MEDICAL DERMATOLOGY CAREER DEVELOPMENT AWARDS . . . . . . . . . . . . . . . . . . . . . . 5

04 CLINICAL CAREER DEVELOPMENT AWARDS IN DERMATOLOGIC SURGERY . . . . . . . . . . . . . . . . . . . 6

04 CLINICAL CAREER DEVELOPMENT AWARD IN HEALTH CARE POLICY . . . . . . . . . . . . . . . . . . . . . . 6

2004 DERMATOLOGIST INVESTIGATOR RESEARCH FELLOWSHIPS . . . . . . . . . . . . . . . . . . . . . . 7

04 RESEARCH CAREER DEVELOPMENT AWARDS . . . . . 8

03 CORPORATE HONOR SOCIETY. . . . . . . . . . . . . . . 10

03 ANNENBERG CIRCLE . . . . . . . . . . . . . . . . . . . . . . 12

03 LEADERS SOCIETY ROSTER. . . . . . . . . . . . . . . . . . 13

04 FELLOWSHIP IN PEDIATRIC DERMATOLOGY . . . . . 20

04 RESEARCH FELLOWSHIPS. . . . . . . . . . . . . . . . . . . 20

04 PATIENT DIRECTED INVESTIGATION GRANTS. . . . . 21

04 ICHTHYOSIS RESEARCH GRANTS . . . . . . . . . . . . . 22

04 DERMATOPATHOLOGY RESEARCH GRANT. . . . . . 22

04 RESEARCH GRANTS. . . . . . . . . . . . . . . . . . . . . . . 22

04 PROGRAM DEVELOPMENT GRANT . . . . . . . . . . . . 22

HONORARY AWARDS . . . . . . . . . . . . . . . . . . . . . . . . 24

EDUCATION FOR TODAY’S PRACTITIONER . . . . . . . . . 26

OTHER CONTRIBUTIONS FROM THE SPECIALTY . . . . . 27

FINANCIAL REPORT . . . . . . . . . . . . . . . . . . . . . . . . . 28

Page 3: DERMATOLOGY

REPORT FROM THE TRUSTEES

At the end of the Dermatology Foundation’s 39th year, we are proud to

report that the Foundation’s mission of advancing patient care by building

research and teaching careers throughout dermatology is strong and on-

going. The Foundation’s continued fund-raising success has enabled us to

fund a record number of investigators throughout medical and surgical dermatology and to once again

expand the Research Awards Program. Starting in 2004 multi-year funding targeted to those pursuing

careers in medical dermatology began in order to build the knowledge-base of medical dermatology

and to address severe dermatologic diseases. (Details on all levels of support begin on page 10.) The

Dermatology Foundation’s multi-faceted commitment to professional education through its publica-

tions—Dermatology Focus and Progress in Dermatology—and CME program—Colloquium on Clinical

Dermatology—provided dermatologists with current and forward-reaching information. And, outreach

to residents continued through the “Better Skin Care through Research” presentation, part of the DF’s

Project Awareness. Since it began in 2000, 1,000 first through third year residents have learned about

the vital role research plays in their training and career development and how the Foundation’s funding

makes this happen.

GOVERNANCE & ADMINISTRATION

The following members of the specialty concluded their terms on the Board of Trustees and have our

profound appreciation for their involvement and guidance: Drs Alistair Carruthers, Barbara A. Gilchrest

and Amy Paller.

Hundreds of members of the specialty volunteer on behalf of the Foundation and its programs.

The Trustees wish to honor the Leaders Society and Annenberg Circle physician network for their fund-

raising successes, the Association of Professors of Dermatology for providing faculty members for the

Annual Colloquium, and the members of the Medical and Scientific Committee and Panels for their

deliberations on applications for the Research Awards Program. Each of these DF constituencies repre-

sents the highest level of commitment within the specialty.

We also recognize the dedicated and determined stewardship of Foundation Executive Director

Sandra Rahn Benz. Since 1979 she has guided the Foundation to its current status in dermatology and

the non-profit world. We appreciate her commitment and look forward to working with her to build on

her first 25 years.

On behalf of our fellow Trustees, we thank all members of the specialty and our corporate partners

for their sustaining support of the Dermatology Foundation’s on-going programs in research and

education. This commitment—over nearly four decades—is shaping the future of dermatology.

Bruce U. Wintroub, M.D. Jouni J. Uitto, M.D., Ph.D.

President Chairman, Board of Trustees

Bruce U. Wintroub, M.D.President

Jouni J. Uitto, M.D., Ph.D.Chairman, Board of Trustees

DERMATOLOGY FOUNDATION

Shaping the

Future of

Dermatology

Page 4: DERMATOLOGY

2 DERMATOLOGY FOUNDATION

The annual achievements of the Leaders Society Campaign, which is

the compelling entity behind the success of the Leaders Society,

involves the work of over 200 dermatologists. The DF recognizes

them not only in the 2003 Leaders Society Roster which begins on

page 13, but in these highlights, including these Campaign State and

Vice Chairs and members of the Board of Trustees who enrolled

three or more new or former Leaders Society members.

RECAPPING 03Record Giving Builds Research and Teaching CareersYear-end results for 2003 show financial support from dermatolo-

gists and industry at record levels: $5.3 million given in support of

the Foundation’s mission to advance patient care by developing

the research and teaching careers of future leaders in medical

and surgical dermatology.

This annual-giving record not only provided for current

needs but raised the Research Endowment Fund to a new high

of $5.4 million.

The generosity of individual dermatologists was impressive:

Giving from over 2,200 individual dermatologists exceeded $2 million for the second consecutive year

Of this cadre of medical and surgical dermatologists, nearly 1,200 contributed $1,000 through the Leaders Society

Membership in the Annenberg Circle with its lifetime commitment of $25,000 grew over 67% to 205 members

Primary Mechanisms for SuccessThe Leaders Society and the Annenberg Circle— reached noteworthy benchmarks in 2003:

15th Anniversary of the Leaders SocietyThe Leaders Society is remarkable not only for its longevity, but for

its vitality and ability to attract new and renewing members. What

began with fewer than 100 colleagues in 1989 has grown consistently

each year, and its members have invested $14 million to advance

patient care by building research and teaching careers in medical

and surgical dermatology. The Dermatology Foundation is proud

to recognize the members of the 2003 Leaders Society on pages

13-19 of this report. Simultaneously, we want to thank a special

group of Leaders Society colleagues who have made this generous

commitment to the specialty early in their careers. Following is a

list of “Young Leaders”—those within their first five years post-

residency—who, as emerging leaders in medical and surgical derma-

tology, challenge all of us to provide for the future of dermatology.

Rodney S. W. Basler, Chair, Nebraska

Ronald R. Brancaccio, Vice Chair, New York/Downstate

Jonith Y. Breadon, Vice Chair, Illinois/Northern

Lawrence L. Bushkell, Vice Chair, Tennessee

Alexander Chiaramonti, Vice Chair, North Carolina

Lisa A. Garner, Chair, Texas/Dallas & Board Campaign

J. Blake Goslen III, Chair, North Carolina

Scott L. Gottlieb, Vice Chair, Pennsylvania/Eastern

Stephen D. Houston, Vice Chair, Texas/San Antonio-Austin

Sewon Kang, Vice Chair, Michigan

Mary P. Lupo, Vice Chair, Louisiana

Frederick A. Lupton, Vice Chair, North Carolina

Darius R. Mehregan, Vice Chair, Michigan

Donald J. Miech, Vice Chair, Wisconsin

O. Fred Miller III, Vice Chair, Pennsylvania/Eastern

Eliot N. Mostow, Vice Chair, Ohio/Northern

Arthur R. Rhodes, Vice Chair, Illinois/ Northern

Richard K. Scher, Chair, New York/ Downstate & Board Campaign

Jimmy D. Schmidt, Vice Chair, Texas/ Houston

Steven K. Shama, Chair, Massachusetts & Board Campaign

John R. Vydareny, Vice Chair, Michigan

John J. Voorhees, Board Campaign

Jonathan S. Weiss, Vice Chair, Atlanta

Bruce U. Wintroub, Board Campaign

Murad Alam, M.D.Julie E. Allee, M.D.Geoffrey C. Basler, M.D.Michael Bobrow, M.D.Anneli R. Bowen, M.D.Amy L. Brodsky, M.D.Clarence W. Brown, Jr.,

M.D.Lance H. Brown, M.D.Timothy S. Brown, M.D.Michael Bukhalo, M.D.Nydia Del R. Camacho-

Padilla, M.D.Jennifer C. Cather, M.D.Julide T. Celebi, M.D.Lawrence K. Chang, M.D.

Justin W. Clark, M.D.Maria I. Colome-Grimmer,

M.D.Karynne O. Duncan, M.D.Matthew P. Evans, M.D.Sharon I. Fairbee, M.D.Scott R. Florell, M.D.Paul J. Frank, M.D.Charles E. Gambla, M.D.Scott L. Gottlieb, M.D.Sergei A. Grando, M.D.,

Ph.D., D.Sc.Douglas Grossman,

M.D., Ph.D.Christiaan P. Hallman, M.D.Iltefat H. Hamzavi, M.D.

Matthew Harris, M.D.Catherine A. Hoffman,

M.D.Victoria L. Holloway, M.D.Sharon L. Horton, M.D.Mary E. Hurley, M.D.Carolyn I. Jacob, M.D.Michelle A. Jahnke, M.D.S. Manjula Jegasothy,

M.D.Beth A. Jester, M.D.Shang I. Brian Jiang, M.D.Darius J. Karimipour, M.D.Kenneth H. Katz, M.D.Julie R. Kenner, M.D.Jonette E. Keri, M.D.,

Ph.D.

Jeffrey Knispel, M.D.Robert A. Koppel, M.D.George Kroumpouzos,

M.D., Ph.D.Han N. Lee, M.D.Ken K. Lee, M.D.Lian-Jie Li, M.D.Jason L. Lockridge, M.D.Christie E. Matter-

Baranski, M.D.Scott W. Meyers, M.D.Craig C. Miller, M.D.Mona Z. Mofid, M.D.Jeffrey G. Moskowitz, M.D.Kevin J. Mott, M.D.Adnan Nasir, M.D., Ph.D.Tho Q. Nguyen, M.D.

Suzan Obagi, M.D.Jeffrey S. Orringer, M.D.Dipa S. Patel, M.D.Lindall A. Perry, M.D.James H. Petrin, M.D.David B. Pharis, M.D.Gary E. Quinby, M.D., Ph.D.Jack S. Resneck, Jr., M.D.Franziska Ringpfeil, M.D.Daniel Roling, M.D.Dana L. Sachs, M.D.David S. Sax, M.D.Lilly H. Schaffer, M.D.Lawrence C. Scherrer,

M.D., Ph.D.Theresa L. Schroeder, M.D.Kimberly K. Schulz, M.D.

Jennifer L. Schwartz, M.D.Quynh L. Sebastian, M.D.Patrick L. Shannon, M.D.Shobana Sood, M.D.Cloyce L. Stetson, M.D.Erik J. Stratman, M.D.Michael J. Suah, M.D.John H. Tu, M.D.Marta J. Van Beek, M.D.Panos Vasiloudes,

M.D., Ph.D.Karl J. Wilkins, M.D.Patricia Wilson, M.D.An Yen, M.D.Jeffrey P. Young, M.D.

YOUNG LEADERS ROSTER

Celebrating 15 Years of Leadership Giving

2003

1999

1994

1989

1,181 members

948 members

711 members

91 members

Building the research and teaching careers of leaders in medical and surgical dermatology

2 DERMATOLOGY FOUNDATION

Regions with 10 or more new Leaders Society members: (in alpha order) California/Bay Area, Illinois/Northern, Massachusetts, Michigan, New York/Downstate, North Carolina & Pennsylvania/Eastern

States with 75 or more Leaders Society members: (in alpha order) California, Florida, Illinois, Michigan, New York, Pennsylvania & Texas

Page 5: DERMATOLOGY

2003 ANNUAL REPORT 3

The most significant outgrowth of the Leaders Society also celebrated an important anniversary.

10th Anniversary of the Annenberg Circle As the Dermatology Foundation’s major gifts program, the Annenberg Circle, whose members make a lifetime commitment of $25,000 over five years, derived from the desire of its 33 Founders to do more to advance patient care by developing researchers and educators in dermatology. Since it was established, the Annenberg Circle has grown to 205 dermatologists and members of the lay public by the end of 2003, and its members’ philanthropy is a significant part of the overall $14 million given through the Leaders Society and Annenberg Circle.

DF Corporate PartnersIndustry’s corresponding response in support of the DF’s mission completed the cycle of generosity.

The $2.3 million given by corporations, specialty societies, and state/regional dermatologic associations assures continuity and growth of research funding as well as DF’s two quarterly professional publications and its annual CME program. In addition to the exceptional, on-going $1 million multi-year commitments of Dermik Laboratories, Inc., Fujisawa Healthcare, Inc., Galderma Laboratories, L.P., Ortho Neutrogena, and Stiefel Laboratories, Inc., the Foundation acknowledges the following Corporate Partners who have earmarked $50,000 or more to the 2004 Research Awards Program. Because the development of research and teaching careers in medical and surgical dermatology is the primary way in which the Dermatology Foundation serves and advances the specialty, this commitment is especially meaningful.

Annenberg Circle 10th Anniversary

2003

1999

1994

205 members

67 members

33 members

Philanthropy for all of dermatology

For All of DermatologyDeveloping the new generation of leaders in research and teaching.

At its annual meeting, the Dermatology Foundation allocated over $3 million to 61 investigators and projects. Over half of the individ-ual awards are directed to the development of research and teaching careers in medical and procedural dermatology through one of the multi-year Career Awards categories. This DF funding of $55,000/year for up to three years provides invaluable career-track continu-ity for investigators throughout the broad spectrum of the specialty’s investigative and teaching arenas.

Avon Products, Inc.Biogen IdecConnetics CorporationDermik Laboratories, Inc.Fujisawa Healthcare, Inc.Galderma Laboratories, L.P.L’Oreal Recherche Medicis, The Dermatology Company®Novartis Pharmaceuticals CorporationOrtho NeutrogenaUnilever Home & Personal Care—U.S.A.

The complete roster of the members of the Foundation’s 2003 Corporate Partnership Program, as well as DF Benefactors, Patrons and Sponsors, appears on pages 10-11.

2003 ANNUAL REPORT 3

Building Research and Teaching CareersTotal awards per category

35

30

25

20

15

10

5

0

11 Basic Skin Research

13

Multi-year Career Awards

1-year Fellowships

1-year Grants

15

6 Dermatologic Surgery

4 Health Care Policy

332 Medical Dermatology

10 Physician-Scientist

Page 6: DERMATOLOGY

4 DERMATOLOGY FOUNDATION

04Physician Scientist Career Development Award

These multi-year awards provide $55,000 annual salary stipends in support of the academic careers of physician-

scientists who are devoted to clinical dermatology. They are designed to assist junior investigators—in the early stages

of their careers—transition from fellowship to established investigator. The researchers pictured here are newly-

funded to pursue the following investigations.

Genomic Programs of Fibroblast DifferentiationSkin from different sites of the body show many differences; they are major clues for derma-tologists to diagnose many diseases. We found that positional memory in skin resides in a class of cells called fibroblasts. Understanding the control and action of fibroblasts genes will provide many answers to how the skin develops, why certain diseases localize to specific sites, and how cancer can spread from one part of the body to another.

Howard Chang, M.D., Ph.D.

Stanford University

Novel Immunotherapy of Malignant Melanoma with Melanosomal AntigensThe creation of cancer vaccines has been challenging. We will generate a new vaccine paradigm using whole recombinant yeast to target malignant melanoma. The efficacy of the vaccine will be studied using developing and pre-existing melanomas in mice. Our study will lead to the development of a practical and powerful vaccine that can be used not only to treat melanoma but to prevent melanoma in the future.

Mayumi Fujita, M.D., Ph.D.

University of Colorado

Generation and Analysis of Langerhans Cells Deficient MiceIn addition to serving as a physical barrier, the skin is also a front-line where cells of the immune system can identify and combat foreign pathogens. Langerhans cells are a key component of this system. We propose to generate several transgenic mouse lines with absent or deficient Langerhans cells in order to clarify the functional roles of these cells in skin immunity and to provide a scientific foundation for their potential therapeutic manipulation.

Daniel H. Kaplan, M.D., Ph.D.

Yale University

lL-12 and Basal Cell Carcinoma: Exploring the lmmunomodulatory Effects of Sonic HedgehogBasal Cell Carcinoma (BCC) is the most common human cancer. While generally not life threatening, BCC can cause significant disfigurement. BCCs are more frequent in chronicallyimmunosuppressed patients. Recently, advances have been made in understanding this cancer ata molecular level. In particular, a set of genes termed the Sonic Hedgehog signaling system (Shh), have been shown to be altered in BCC. We will explore how Shh affects local immunity to allow tumor growth.

David J. Kouba, M.D., Ph.D.

Johns Hopkins University

Page 7: DERMATOLOGY

2003 ANNUAL REPORT 5

The Role of the Skin Barrier in Atopic Dermatitis Development and PreventionAtopic dermatitis is a common, intensely itchy, inflammatory skin disease that affects between 10-20% of children. Despite its increasing prevalence, there are no generally accepted recommen-dations for the prevention of atopic dermatitis. Recent research suggests a defective skin barrier may be an important factor in the development of this chronic disease. We propose that early skin protection with a safe barrier-protecting ointment in infants may prevent or delay the development of atopic dermatitis.

Eric L. Simpson, M.D.

Oregon Health & Science University

Molecular Mechanisms of Melanosome BiogenesisHermansky-Pudlak Syndrome (HPS) is a rare disorder caused by a single gene defect that affects the skin, eyes, lungs, colon, immune system, and blood clotting system. Six different genes are known to cause HPS in humans, but the way that these genes work is not understood. This proposal focuses on the detailed study of one HPS gene, cappuccino, to analyze how defects in this gene can cause multisystem disease.

This new category of multi-year awards is designed to develop future intellectual leaders, educators and clinical scholars

in those aspects of dermatology that address severe, systemic dermatologic disease. It provides $55,000 annual salary

stipends for up to three years, and the investigators pictured here are newly-funded to pursue the following projects.

Defining and Evaluating Targets for Treatment of Skin Disease in Systemic SclerosisMost research in scleroderma focuses on treatment and prevention of internal organ damage. My interest is in understanding and treating the debilitating effects of skin fibrosis. Drugs that regulate cutaneous blood flow as well as the immune system will be evaluated. I will seek to identify genes whose differential regulation may be involved in triggering the disease, and that could be the target of future therapies for this devastating disease.

David Fiorentino, M.D., Ph.D.

Stanford University

A Proposal for the Development of Expertise in Consultative Medical Dermatology with a Specific Emphasis on the Study of the Impact of Stem Cell Allografts with Retained Versus Diminished Graft-Versus-Tumor Effects on Acute Graft-Versus-Host Disease and T-Cell Mediated Cutaneous DiseasesA plan for development of the candidate into a leader in the field of Medical Dermatology isproposed. Prevention of the dangerous skin reaction that follows stem cell transplants from non-identical individuals will be attempted. Benefit of stem cell transplants on pre-existing inflammatory skin diseases, such as psoriasis, will also be determined. The candidate’s ability to translate understanding of the basis of skin diseases into novel therapies will be enhanced through advanced multifaceted clinical training.

Lindy P. Fox, M.D.

Yale University

04Medical Dermatology Career Development Award

Maria L. Wei, M.D., Ph.D.

University of California, San Francisco

Page 8: DERMATOLOGY

6 DERMATOLOGY FOUNDATION

This multi-year award supports research projects that will further the practice of dermatologic surgery and develop the

research and teaching careers of its future leaders. It provides $55,000 annual salary stipends for up to three years, and

the investigators pictured here are newly-funded to pursue the following projects.

Enabling Remote Skin Cancer Diagnosis and Treatment Over the Internet: Creating and Validating Touch Technology for TeledermatologySkin cancer is the most prevalent form of cancer in the United States. Early diagnosis and treatment of skin cancer can decrease its morbidity and mortality. Teledermatology has been used for geographically remote patients. A limitation of this modality is the lack of tactile feedback. Developing the ability to touch the remote patient’s lesion will increase the diagnostic accuracy. This tactile feedback can be used for training and applied to other aspects of dermatologic surgery.

Hayes B. Gladstone, M.D.

Stanford University

Microdermabrasion and Dermal RemodelingMicrodermabrasion is rapidly becoming a popular procedure for improving fine rhytides and pigmentary abnormalities associated with photo aging, enlarged pores, and scarring. Several studies have evaluated the clinical and histologic changes associated with microdermabrasion, however, our understanding of the molecular mechanisms underlying these changes is still in its infancy. We propose to evaluate changes in barrier lipid biosynthesis, inflammatory cytokines,matrix metalloproteinases, and collagen synthesis after microdermabrasion treatment.

Darius J. Karimipour, M.D.

University of Michigan

04Clinical Career Development Award in Dermatologic Surgery

This category of multi-year awards, established in 1995, provides $55,000 annual salary stipends for those

dermatologists seeking to develop careers in health care policy. The investigator pictured here is newly-funded to

pursue the following project.

Epidemiology of Skin Cancer: A Population-Based Approach This proposal addresses the need for clinical research in dermatology by focusing on two important aspects of skin cancer research: validation of a Skin Cancer Risk Estimation and Evaluation (SCREEN) tool and use of SCREEN to collect data on natural history of skin cancer. As part of this work, an online version of SCREEN will be developed allowing outreach to a larger segment of the U.S. population via an internet-based long-term study.

Abrar A. Qureshi

Harvard Medical School

04Clinical Career Development Award in Heath Care Policy

Page 9: DERMATOLOGY

2003 ANNUAL REPORT 7

04Dermatologist Investigator Research Fellowship

This category of funding is designed to provide a $30,000 salary stipend for one year to support dermatologists

seeking to develop research skills and to apply this training in their commitment to academic careers in medical

or surgical dermatology.

In Vitro and In Vivo Study of the Interaction of Vaccinia Virus with Langerhans Cells in the Presence or Absence of Antipoxvirus DrugOur goal of this research project is to study the pathogenesis of poxvirus and the mechanism of action of antipoxvirus drugs. We hope to develop a murine skin model using engineered poxvirus to study viral pathogenesis and host immune defense. This model will allow us to evaluate the efficacy of topical antipoxvirus drugs in the treatment of poxvirus infection of the skin and complications of smallpox vaccine.

Liang Deng, M.D., Ph.D.

George Washington University

The Role of Epiderman Transglutaminase in Dermatitis HerpetiformisDermatitis herpetiformis (DH) is a skin eruption that is a manifestation of gluten sensitivity. Epidermal transglutaminase (eTG) appears to be the dominant autoantigen in DH. This project will expand our understanding of the pathogenesis of DH by correlating IgA eTG antibody levels with factors related to disease severity, purifying eTG and developing polyclonal antibodies to this protein, and evaluating expression of eTG in relationship to skin lesions of DH.

Christopher M. Hull, M.D.

University of Utah

Gene Expression Analysis of Leprosy Reactional States to Gain Insights into Type III and Type IV Immune Responses in SkinLeprosy provides an extraordinary model to investigate mechanisms of cell-mediated immunity and unresponsiveness to intracellular pathogens in humans. The outcome of the host response to M. leprae is determined by the nature of the immune response in lesions. I propose to futher understand the mechanisms of tissue injury by analyzing the reactional states of leprosy, erythema nodosum leprosum and reversal reaction. From this information I anticipate developing new treatments for a variety of infectious diseases.

Delphine J. Lee, M.D., Ph.D.

University of California, Los Angeles

Innate Immunity to Bacterial Skin InfectionsThe majority of cutaneous bacterial infections in humans is due to Staphylococcus aureus and Group A Streptococcus. This proposed study will investigate the role of Toll-like receptors (TLRs), particularly TLR2, in mediating immune responses and generation of antimicrobial peptides directed against these common bacterial skin infections. This study will broaden our understanding of cutaneous host defense and may lead to much needed novel antibacterial therapies, thereby expanding our arsenal against these infections.

Lloyd S. Miller, M.D., Ph.D.

University of California, Los Angeles

Role of GILT in MHC Class II Processing and PresentationMany benign and malignant dermatologic diseases, such as psoriasis, eczema and cutaneous T cell lymphoma, are mediated by activated CD4+ T cells, specialized immune cells. Dendritic cells, which express major histocompatibility complex (NIHC) class II molecules, are the major activators of CD4+ T cells. Gamma-interferon-inducible lysosomal thiol reductase (GILT) is an enzyme that breaks down proteins in the MHC class II pathway. Mice that lack GILT will be utilized to determine the role of GILT in dendritic cells and in the development of dermatologic diseases.

Karen S. Taraszka, M.D.

Yale University

Page 10: DERMATOLOGY

8 DERMATOLOGY FOUNDATION

Phenotypic and Functional Characterization of Memory B Cells Autoimmune blistering disorders such as pemphigus and bullous pemphigoid are potentially fatal diseases caused by antibodies that bind to proteins that hold skin cells together. B cells produce these antibodies, but the mechanisms responsible for their sustained antibody production (memory) are poorly understood. Here, we propose to study B cell memory, which allows for chronic autoantibody production. This will allow more directed therapies to be developed.

Mary M. Tomayko, M.D., Ph.D.

Yale University

Is Isotretinoin Use Associated with an Increased Risk of Depression or Suicide in the U.S.? High-profile cases in the lay press have drawn increasing attention to a possible link between isotretinoin use and an increased risk of depression or suicide among patients with acne. However, no scientific studies have been able to convincingly demonstrate any such increased risk. This study intends to be the largest epidemiologic investigation on this subject to date and the first such study examining data from the United States.

Lee T. Zane, M.D.

University of California, San Francisco

04Research Career Development Awards

These multi-year awards are designed to assist junior investigators —in the early stages of their careers—transition

from fellowship to established investigator. They provide $55,000 annual salary stipends, and the researchers pictured

here are newly-funded to pursue the following investigations.

Skin Manifestations of Tuberous SclerosisTuberous Sclerosis (TS) is a genetic problem that causes morbidity and mortality due to developmental malformations, resulting in seizures, as well as benign and malignant tumors. This proposal will test the hypotheses that these lesions are caused by abnormal growth factor receptor activation, and that combination of FDA approved tyrosine kinase receptor antagonists with systemic retinoids may be beneficial in the treatment of TS. Combination therapy with kinase inhibitors and retinoids may be therapeutically useful in a wide range of neoplastic and inflammatory disorders.

Baskaran Govindarajan, Ph.D.

Emory University

Designer Cocktail Adjuvants for Cancer TreatmentDendritic cells (DC) are special leukocytes that play key roles in initiating immune responses.We have observed recently that maximal DC activation is achievable by combining multiplepharmacological agents. Using our newly developed DC-based “biosensor” systems, we willformulate the optimal “designer cocktail” adjuvants. Subsequently, we will determine whetherprotective immunity against cancer is inducible by this approach. We believe that the proposedstudy may lead to the development of new therapies for cancer patients.

Norikatsu Mizurnoto, M.D., Ph.D.University of Texas, Southwestern Medical Center

Genomic and Functional Analysis of FGF Antagonists in MelanomaMelanoma remains one of the most serious forms of cancer. Identification of new genes involved in melanoma have led to important insights into the origins of this cancer and to potential therapeutic targets. Mutations which affect RAS signaling have been identified in the large majority of melanomas. We will investigate what role the inhibitors of the RAS signaling pathway play in normal melanocytes and why they fail to block the progression of melanoma.

Benjamin Yu, M.D., Ph.D.

University of California, San Francisco

Page 11: DERMATOLOGY

2003 ANNUAL REPORT 9

04Award Renewals

Physician Scientist Career Development Award

Renewal Year 2

Rachael A. Clark, M.D., Ph.D. Brigham and Women’s HospitalProduction of Human T Cells Using a Skin-Derived Thymus Construct

Renewal Year 3

Sumayah Jamal, M.D., Ph.D. New York UniversityRegulation of E-Cadherin and MCAM in Melanocytes and Melanoma Cells by Endothelin-1

Alexandra Boer Kimball, M.D., M.P.H. Stanford UniversityLaminin 5 Beta 3 Gene Transfer for Junctional Epidermolysis Bullosa

Michael E. Ming, M.D. University of PennsylvaniaDevelopment of Clinically Useful Models for Predicting the Occurrence of Second Primary Melanomas

Research Career Development Award

Renewal Year 2

Tatiana Efimova, Ph.D. Case Western Reserve Universityp38 Delta Signaling and Regulation of Apoptosis in Keratinocytes

Walter G. Hubert, Ph.D. University of ArkansasDNA Replication of Different Human Papillomaviruses Following Coinfection

Yuangang Liu, Ph.D. Oregon Health Sciences UniversityNovel AAA-Protein SPAF in Apoptosis and Melanoma

Zhongkai Shi, M.D. University of Alabama, BirminghamEpicutaneous Anthrax Vaccine by E. Coli Carrier

Renewal Year 3

Carlos Caulin, Ph.D. Baylor College of MedicineAntitumor Effects of TRAIL (Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand) in Skin Carcinogenesis

Fatima Rouan, Ph.D. Thomas Jefferson UniversityConnexin Biology and Pathology of Connexin Human Disorders Affecting the Skin

Maria S. Soengas, Ph.D. University of MichiganInactivation of Apoptotic Factors in Melanoma, Impact on Tumor Progression, Metastasis and Chemoresistance

Peter I. Song, Ph.D. Northwestern UniversityThe Expression and Function of Keratinocyte CD14 and TLR2/TLR4

Clinical Career Development Award in Health Care Policy

Renewal Year 2

Joel M. Gelfand, M.D. University of PennsylvaniaThe Incidence of Cancer in Psoriasis Patients

Jack S. Resneck, Jr., M.D. University of California, San FranciscoNew Methods for Examining Dermatology Workforce Adequacy

Renewal Year 3

Sarah L. Chamlin, M.D. Children’s Memorial HospitalQuality of Life in Children with Atopic Dermatitis: Instrument Development, Testing and Refinement

Clinical Career Development Award in Dermatological Surgery

Renewal Year 2

John A. Carucci, M.D., Ph.D. Cornell UniversityIdentification of Epidemiological Risk Factors and Elucidation of Molecular Mechanisms Involved in Development of Catastrophic Cutaneous Carcinogenesis in Organ Transplant Recipients

Renewal Year 3

Kristen M. Kelly, M.D. University of California, IrvineOptimizing Laser Treatment of Port Wine Stain Using Cryogen Spray Cooling

Ken K. Lee, M.D. Oregon Health Sciences UniversityUse of Optical Imaging in the Evaluation of Skin Pathology

Jeffrey S. Orringer, M.D. University of MichiganNon-ablative Laser Therapy: Biochemical Mechanisms and Clinical Correlation

Page 12: DERMATOLOGY

10 DERMATOLOGY FOUNDATION

2003 CORPORATE PARNERSHIP PROGRAM

Platinum Benefactor ($200,000 to 500,000)

Dermik Laboratories, Inc. Fujisawa Healthcare, Inc. Galderma Laboratories, L.P. Ortho Neutrogena

Gold Benefactor ($100,000 to 199,999)

Biogen IdecConnetics CorporationMedicis, The Dermatology Company ®Stiefel Laboratories, Inc. Unilever Home & Personal Care–U.S.A.

Silver Benefactor ($50,000 to 99,999)

3M PharmaceuticalsAllergan Skin CareAmerican Academy of DermatologyAmgen, Inc.Avon Products, Inc.Centocor, Inc.Ferndale Laboratories, Inc.Genentech, Inc.L’Oreal RechercheNovartis Pharmaceuticals Corporation

Partners in Fulfilling the Foundation’s Mission of Shaping the Future of DermatologyThe Trustees express appreciation to all corporate benefactors who support the Research Awards Program as well as

Foundation publications, lectureships, the Annual Colloquium and the Leaders Society recognition program.

❉ $1 million pledge

Page 13: DERMATOLOGY

2003 ANNUAL REPORT 11

2003 BENEFACTORS, PATRONS AND SPONSORSThe Trustees also express appreciation to the following specialty societies, organizations and companies for their

help in underwriting the Foundation’s Research Awards Program, continuing medical education program and

sprofessional publications.

Distinguished Benefactor II ($40,000 to 49,999)

F.I.R.S.T.Valeant Pharmaceuticals International

Distinguished Benefactor I ($25,000 to 39,999)

Abbott ImmunologyAlmay Inc.Bioglan Pharmaceuticals CompanyMary Kay, Inc.Pfizer, Inc.Society for Investigative Dermatology

Benefactor III ($10,000 to 24,999)

American Society of DematopathologyBarrier Therapeutics, Inc.Berlex LaboratoriesHealthpoint, Ltd.INAMED CorporationMerz PharmaceuticalsProcter & Gamble CompanySociety for Pediatric Dermatology

Benefactor II ($5,000 to 9,999)

Dow Pharmaceutical SciencesNoah Worcester Dermatological SocietySkinMedica, Inc.

Benefactor I ($2,500 to 4,999)

Georgia Society of Dermatologists

Pacific Dermatologic Association

Patron ($1,000 to 2,499)

Acuderm, Inc.Alabama Dermatology SocietyBuffalo-Rochester Dermatology

SocietyChicago Dermatological SocietyNew England Dermatological

SocietyPathology AssociatesPittsburgh Academy of

DermatologyVirginia Dermatological

Society, Inc.Wisconsin Dermatological

SocietyWomen’s Dermatologic Society

Sponsor ($100 to 999)

Ohio Dermatological Association, Inc.

Page 14: DERMATOLOGY

12 DERMATOLOGY FOUNDATION

From the SpecialtyTina S. Alster, M.D. ✵Rex A. Amonette, M.D. ✵Thomas W. Andrews, M.D.Diane R. Baker, M.D.Joel R. Barkoff, M.D.Rodney S.W. Basler, M.D. ✵

Eugene A. Bauer, M.D.Paul W. Becker, M.D.Paul R. Bergstresser, M.D.Susan Bershad, M.D.✵Karl R. Beutner, M.D., Ph.D.Jag Bhawan, M.D.David R. Bickers, M.D. ✵Kenneth B. Bielinski, M.D.Joseph B. Bikowski, M.D.John Q. Binhlam, M.D. Jay E. Birnbaum, Ph.D.Marshall L. Blankenship, M.D.✵ Ronald R. Brancaccio, M.D.Martin Braun III, M.D.Jonith Y. Breadon, M.D.Robert A. Briggaman, M.D.Robert T. Brodell, M.D. Stuart M. Brown, M.D.Lawrence L. Bushkell, M.D.Jeffrey P. Callen, M.D.Valerie D. Callender, M.D.Robert G. Carney, Jr., M.D.Roger I. Ceilley, M.D.Marvin E. Chernosky, M.D.✵

Neldagae S. Chisa, M.D.Clay J. Cockerell, M.D.Lisa M. Cohen, M.D.Brett M. Coldiron, M.D.C. Ralph Daniel III, M.D.William P. Davey, M.D.Vincent A. DeLeo, M.D.William Dorner, Jr., M.D.Dan A. Dunaway, M.D.W. Christopher Duncan, M.D.Gary A. Dyer, M.D.Madeleine Duvic, M.D.Richard L. Edelson, M.D.Peter G. Ehrnstrom, M.D.Boni E. Elewski, M.D. ✵Charles N. Ellis, M.D.Melvin L. Elson, M.D. ✵Ervin H. Epstein, Jr., M.D.John H. Epstein, M.D. ✵William L. Epstein, M.D.James O. Ertle, M.D.Janet A. Fairley, M.D.Patricia Farris, M.D.Patrick R. Feehan, M.D.Steven R. Feldman, M.D., Ph.D.

Frederick S. Fish III, M.D.Richard E. Fitzpatrick, M.D.Helen Flamenbaum, M.D.Irwin M. Freedberg, M.D.Phillip Frost, M.D. ✵J. Harvey Gardner, M.D.Lisa A. Garner, M.D.Barbara A. Gilchrest, M.D.Anita C. Gilliam, M.D., Ph.D.Robert F. Godwin, M.D.Michael H. Gold, M.D.David J. Goldberg, M.D.Harry M. Goldin, M.D.Mitchel P. Goldman, M.D.Gloria F. Graham, M.D.James H. Graham, M.D.Robert D. Greenberg, M.D.George W. Hambrick, Jr., M.D.John R. Hamill, Jr., M.D.C. William Hanke, M.D.John M. Haraldsen, M.D.Thomas D. Harris, M.D.Harley A. Haynes, M.D.Warren R. Heymann, M.D.Jean M. Holland, M.D.Coleman Jacobson, M.D. ✵Marie-Louise Johnson, M.D., Ph.D.Richard A. Johnson, M.D.Timothy M. Johnson, M.D.Waine C. Johnson, M.D.Robert E. Jordon, M.D.William D. Ju, M.D.John B. Kalis, M.D.Jay C. Klemme, M.D.Albert M. Kligman, M.D., Ph.D. ✵Gerald G. Krueger, M.D.Thomas Kupper, M.D.Marilyn S. Kwolek, M.D.Walter G. Larsen, M.D.Francis C. Lee, M.D.Robert G. Lee, M.D.David J. Leffell, M.D. Albert M. Lefkovits, M.D.James J. Leyden, M.D. ✵Henry W. Lim, M.D.Marketa Limova, M.D.Mary P. Lupo, M.D.James D. Maberry, M.D.David D. Madorsky, M.D.Michael G. Mancuso, M.D.Eugene Mandrea, M.D.Barbara M. Mathes, M.D.Elizabeth I. McBurney, M.D.Robert E. McCallister, M.D.Robert J. McNamara, M.D.Alan Menter, M.D. ✵

Andrew L. Messenger, M.D.Gregory G. Messenger, M.D.D. Scott Miller, M.D.Stanley J. Miller, M.D.Warwick L. Morison, M.D.Ronald L. Moy, M.D.Peter J. Muelleman, M.D.M. Gayle Mullanax, M.D.Howard Murad, M.D. ✵Douglas N. Naversen, M.D.Lee T. Nesbitt, Jr., M.D.Dennis E. Newton III, M.D.David A. Norris, M.D.Marianne N. O’Donoghue, M.D.Margaret E. Olsen, M.D. ✵Thomas G. Olsen, M.D. Richard E. Otoski, M.D.Gerald G. Overly, M.D. ✵Lafayette G. Owen, M.D.John A. Parrish, M.D.William T. Parsons, M.D. ✵Nicholas V. Perricone, M.D.R. Todd Plott, M.D.Rhonda Rand, M.D.Ronald P. Rapini, M.D.Barbara R. Reed, M.D.Lisa J. Renfro, M.D.Arthur R. Rhodes, M.D., M.P.H.Phoebe Rich, M.D.Julee K. Richards, M.D.Mitchell A. Rinek, M.DRoy S. Rogers III, M.D.Robert L. Roschel, M.D.Jill R. Rosenthal, M.D.Louis Rubin, M.D.Neil S. Sadick, M.D.Leslie F. Safer, M.D.Richard K. Scher, M.D. ✵Jimmy D. Schmidt, M.D. ✵Bryan C. Schultz, M.D. ✵Alan R. Shalita, M.D. ✵Steven K. Shama, M.D., M.P.H. ✵Albert Shapiro, M.D. ✵Christopher R. Shea, M.D.Laurence A. Sibrack, M.DDaniel M. Siegel, M.D.David N. Silvers, M.D.Kristin W. Smallwood, M.D.Mary C. Spellman, M.D.John R. Stanley, M.D.Daniel M. Stewart, D.O.Roger H. Stewart, M.D.Hiram M. Sturm, M.D.Neil A. Swanson, M.D.Robert A. Swerlick, M.D.Leonard J. Swinyer, M.D.

Mark B. Taylor, M.D.Maurice A. Thew, M.D.Diane M. Thiboutot, M.D.Robert E. Tigelaar, M.D.Helen M. Torok, M.D.Ben M. Treen, M.D. ✵James E. Turner, M.D., Ph.D.Stephen K. Tyring, M.D., Ph.D.Jouni J. Uitto, M.D., Ph.D. ✵

Eugene J. Van Scott, M.D. ✵John J. Voorhees, M.D.Donald S. Waldorf, M.D. ✵Patricia S. Walker, M.D., Ph.D.Wallace N. Weber, M.D.Stephen B. Webster, M.D.Robert A. Weiss, M.D.Howard G. Welgus, M.D.W. Phillip Werschler, M.D.Bruce U. Wintroub, M.D.Allan S. Wirtzer, M.D.David T. Woodley, M.D.Mitchell S. Wortzman, Ph.D.James A. Yeckley, M.D.Ruey J. Yu, Ph.D., O.M.D. ✵Herschel S. Zackheim, M.D.Nardo Zaias, M.D.John J. Zone, M.D.

From the PublicDouglas CanfieldStephen W. ClarkDavid D. FadnessGavin S. Herbert ✵Ira Lawrence, M.D.Thomas L. Mehl, Sr.Glenn A. OclassenJonah Shacknai ✵

Charles W. StiefelWerner K. StiefelThomas G. Wiggans

✵ Annenberg Circle Founder

03 Annenberg Circle

At the close of 2003, membership reached 205 dermatologists and lay members. The Trustees are deeply appreciative of the generosity of these individuals. Their commitment helps ensure the growth of the Foundation’s programs. Up to $10,000 of accrued Leaders Society membership can be applied to Annenberg Circle participation.

12 DERMATOLOGY FOUNDATION

Page 15: DERMATOLOGY

2003 ANNUAL REPORT 13

03Leaders Society Roster

This year we celebrate an important milestone for all of dermatology. For 15 years

the Leaders Society has challenged each of us to give generously every year to

support the research/teaching component of the specialty. As a result, members of

the Leaders Society, combined with Annenberg Circle members, have given more

than $14 million since 1989 to improve patient care by sustaining dermatology’s

infrastructure. What began with a cadre of 91 original members has now grown to

over 1,100 members, and the Dermatology Foundation is honored to recognize these

individuals as members of the 2003 Leaders Society and Annenberg Circle.

Through their 2003 contributions, they have provided over $1.98 million to

advance the entire specialty. We hope their example prompts you to make your own

generous commitment. In this way, you, too, will be a partner in sustaining medical

and surgical dermatology and will gain personal and professional satisfaction from

knowing that it is our patients who are the ultimate beneficiaries.

AlabamaChair Ruth A. Yates, M.D.

Vice Chairs Vera Y. Soong, M.D. Patricia Wilson, M.D.

Robert B. Ash, M.D. Ralph R. Braund, Jr., M.D. Robert W. Calcote, M.D. Brian D. Cheshire, M.D. Robert A. Clark, M.D. James E. Elder, M.D. Boni E. Elewski, M.D.◆ Craig A. Elmets, M.D. Charles E. Gambla, M.D. Sharon Foster Gardepe, M.D. Christopher B. Harmon, M.D. Robert E. Jones, M.D. James M. Krell, M.D. Jason L. Lockridge, M.D. Steve L. Mackey, M.D. Gary D. Monheit, M.D. Leonard T. Pynes, M.D. Lon F. Raby, Jr., M.D. Deborah Y. Sanders, M.D. John K. Sowell, M.D. Julian M. Thomas, M.D. George G. Tisdale, M.D. Joseph M. Webb, M.D. William R. Welborn, Jr, M.D.

AlaskaChair Douglas N. Naversen, M.D.

Peter G. Ehrnstrom, M.D.

ArizonaChair Elaine P. Young, M.D.

Vice Chairs Marc I. Epstein, D.O. Mary F. Fredenberg, M.D.

Evan G. Bauer, M.D. Carl F. Bigler, M.D. Norman E. Bystol, M.D. Suzanne M. Connolly, M.D. Mark V. Dahl, M.D. Paul E. English, M.D. David N. Flieger, M.D. John M. Haraldsen, M.D. Richard J. Havens Therese A. Holguin, M.D. Richard A. Hoshaw, M.D. Michael J. Huether, M.D. R. Todd Plott, M.D. Henry H. Roenigk, Jr., M.D. Jonah Shacknai◆ Mitchell Wortzman, Ph.D.

ArkansasJere D. Guin, M.D. Thomas D. Horn, M.D. Dow B. Stough IV, M.D.

California—Bay AreaChair Seth L. Matarasso, M.D.

Vice Chairs Timothy G. Berger, M.D. David C. Gorsulowsky, M.D. Donald Kay, M.D. Amelia H. Kaymen, M.D. Marilyn S. Kwolek, M.D.

California—Los AngelesChair David T. Woodley, M.D. Vice Chair Han N. Lee, M.D.

California—SacramentoChair Fu-Tong Liu, M.D., Ph.D.

Vice Chair

Sergei A. Grando, M.D., Ph.D., D.Sc.

California—San DiegoChair Lawrence F. Eichenfield, M.D.

Kim M. Albridge, M.D. Kenneth S. Alpern, M.D.Todd S. Anhalt, M.D. Ronald J. Barr, M.D. Eugene A. Bauer, M.D. Louis Bauman, M.D. Robert E. Beer, M.D. Karl R. Beutner, M.D., Ph.D. Meda E. McCarley Billys, M.D. Jeffrey T. Bortz, M.D.

Barbara A. Burrall, M.D.Kimberly J. Butterwick, M.D. Andrew S. Calciano, M.D. Ivor Caro, M.D. Lani E. Clark, M.D. Greta Fields Clarke, M.D. Marcus A. Conant, M.D. Michael W. Condie, M.D. Peggy S. Crawford, M.D. Patrick R. Dahl, M.D. Karynne O. Duncan, M.D.

Beverly A. Epstein, M.D. Ervin H. Epstein, Jr., M.D. John H. Epstein, M.D. ◆ William L. Epstein, M.D. Sheila Fallon Friedlander, M.D. Erlinda S. Fang, M.D. Michael J. Fazio, M.D. Kathy A. Fields, M.D. Richard E. Fitzpatrick, M.D. Michael J. Franzblau, M.D. Ilona J. Frieden, M.D. John K. Geisse, M.D. Ruby Ghadially, M.D Richard G. Glogau, M.D. Mitchel P. Goldman, M.D. Peter M. Goldman, M.D. Sanford M. Goldstein, M.D. Joseph H. Greenberg, M.D. Pearl E. Grimes, M.D. Karyn L. Grossman, M.D. Christiaan P. Hallman, M.D. David R. Harris, M.D. Roland Hart, M.D. Robert Hartman, M.D. Gavin S. Herbert ◆ Julie A. Hodge, M.D., M.P.H. Catherine A. Hoffman, M.D. Vincent C. Hung, M.D. Leo Indianer, M.D. James D. Jacobitz, M.D. Stuart I. Jacobs, M.D. Gail Tenikat Jacoby, M.D. Lenore S. Kakita, M.D. Matthew H. Kanzler, M.D. Suzanne L. Kilmer, M.D. Janice P. Kim, M.D. Laura A. King, M.D. Arnold W. Klein, M.D.

15 Years of Leadership Giving

Leaders Society CommitteeMichael D. Tharp, M.D., ChairStuart R. Lessin, M.D., Vice Chair

Rodney S. W. Basler, M.D.James O. Ertle, M.D.Lisa A. Garner, M.D.Elizabeth I. McBurney, M.D.William S. Sawchuk, M.D.Richard K. Scher, M.D.Steven K. Shama, M.D., M.P.H.Richard D. Sontheimer, M.D.

Page 16: DERMATOLOGY

14 DERMATOLOGY FOUNDATION

Pui-Yan Kwok, M.D., Ph.D. Alfred T. Lane, M.D. Nikolajs A. Lapins, M.D. Glenn N. Ledesma, M.D. John A. Lenahan, M.D. Marketa Limova, M.D. Nicholas J. Lowe, M.D. Jamie L. MacDougall, M.D. Toby A. Maurer, M.D. Theodora M. Mauro, M.D. Camilla S. McCalmont, M.D. Robert J. McNamara, M.D. Brian P. Mekelburg, M.D. Robert M. Melnikoff, M.D. Allison E. Nicholas Metz, M.D. Richard Mihan, M.D. Robert L. Modlin, M.D. Ronald L. Moy, M.D. Howard Murad, M.D. ◆ F. Richard Noodleman, M.D. Glenn A. Oclassen Margaret E. Olsen, M.D. ◆ Daniel J. Piacquadio, M.D. Peter A. Pollat, M.D. Jerome R. Potozkin, M.D. Norman M. Price, M.D. Vera H. Price, M.D. Rhonda Rand, M.D. Vail C. Reese, M.D. Mark S. Reisman, M.D. Jack S. Resneck, Jr., M.D. Kathryn P. Rodan, M.D. Megin C. Scully, M.D. Quynh L. Sebastian, M.D. Jerral S. Seibert, M.D. Ava T. Shamban, M.D.Stacy R. Smith, M.D. Mary C. Spellman, M.D. Cheryl A. Tanasovich, M.D. Whitney D. Tope, M.D. Abel Torres, M.D. Denny L. Tuffanelli, M.D. Jane S. Wada, M.D. Gary Wagner, M.D. Barry A. Waldman, M.D.Patricia S. Walker, M.D., Ph.D. Ken Washenik, M.D., Ph.D. John W. Weiss, M.D. Thomas G. Wiggans Karl J. Wilkins, M.D. Bruce U. Wintroub, M.D. � Allan S. Wirtzer, M.D. Gail Wong, M.D. An Yen, M.D. Christopher B. Zachary, M.D. Herschel S. Zackheim, M.D.

ColoradoChair Adrienne E. Stewart, M.D.

Maida L. Burrow, M.D. James E. Fitzpatrick, M.D. Loren E. Golitz, M.D.

James C. Huff, M.D. Bruce W. Kornfeld, M.D. Patrick J. Lillis, M.D. J. Michael Maloney, M.D. David A. Norris, M.D. Perry L. Rashleigh, M.D. Barbara R. Reed, M.D. Kathleen Y. Sawada, M.D. John J. Schmidt, M.D. Brent C. Sigler, M.D.

ConnecticutChair Philip E. Shapiro, M.D.

Vice Chairs Lisa M. Donofrio, M.D. Michael Girardi, M.D. Alicia D. Zalka, M.D.

Jean L. Bolognia, M.D. Ivan S. Cohen, M.D. Kenneth A. Cohen, M.D. Kevin M. Diette, M.D. Richard L. Edelson, M.D. Michele E. Gasiorowski, M.D. Robert D. Greenberg, M.D. Jeffrey Knispel, M.D. Steven A. Kolenik III, M.D. Robert C. Langdon, M.D. David J. Leffell, M.D. Leon E. Luck, M.D. Jennifer Madison McNiff, M.D. Joan M. Mones, D.O. Maritza I. Perez, M.D. Nicholas V. Perricone, M.D. Ronald C. Savin, M.D. Jeffrey S. Schechner, M.D. Laurence A. Sibrack, M.D. Robert E. Tigelaar, M.D. Kalman L. Watsky, M.D. Jonathan R. Zirn, M.D.

DelawareChair Maurice A. Thew, M.D.

Peter B. Panzer, M.D. Scott M. Panzer, M.D. Mitchell Stickler, M.D.

District of ColumbiaChair William S. Sawchuk, M.D.

Vice Chairs Mervyn L. Elgart, M.D. Lynn J. McKinley-Grant, M.D.

Tina S. Alster, M.D. ◆ Martin Braun III, M.D. Cheryl M. Burgess, M.D. Rebat M. Halder, M.D. Beverly A. Johnson, M.D. M. Carol McNeely, M.D.

Florida—North/CentralChair Albert J. Nemeth, M.D.

Vice Chairs Sharon I. Fairbee, M.D. Michael J. Freeman, M.D. John R. Hamill, Jr., M.D. Terrence T. Hopkins, M.D. John C. Long, Jr., M.D. Susan L. Malane, D.O. Jeffrey D. Parks, M.D. Oliver M. Reed, M.D. William J. Roth, M.D., Ph.D. Panos Vasiloudes, M.D., Ph.D. Jennifer L. Vesper, M.D. Susan H. Weinkle, M.D.

Florida—SouthChair S. Manjula Jegasothy, M.D.

Vice Chairs Keyvan Nouri, M.D. Leslie B. Rosen, M.D. Steven D. Shapiro, M.D.

Mary F. Barber, M.D. Leslie Baumann, M.D. Fredric S. Brandt, M.D. Teresa Pullara Brandt, M.D. Charles Camisa, M.D. Michael G. Caruso, M.D. Stephen E. Chiarello, M.D. Bernard H. Cohen, M.D. Christopher P. Crotty, M.D.Judith E. Crowell, M.D. Peter Donelan, M.D. W. Christopher Duncan, M.D. N. Fred Eaglstein, D.O. William H. Eaglstein, M.D. Lowella E. Esperanza, M.D. Neil A. Fenske, M.D. Robert P. Finkelstein, D.O. Theodore N. Fotopoulos, M.D. Anthony F. Fransway, M.D. Phillip Frost, M.D. ◆ Brian A. Harris, M.D. Sidney Indgin, M.D. Tim Ioannides, M.D. Stanley E. Jacobs, M.D. Robert H. Johr, M.D. Timothy F. Kelly, M.D.Jonette E. Keri, M.D., Ph.D. Timothy M. Kilpatrick, M.D.Robert S. Kirsner, M.D. Ronald C. Knipe, M.D Susana M. Leal-Khouri, M.D. Donald P. Lookingbill, M.D. Stephen H. Mandy, M.D. Gary L. Marder, D.O. Thomas L. Mehl, Sr. Dan H. Meirson, M.D. John L. Meisenheimer, Jr., M.D. John L. Millns, Jr., M.D. Jeffrey G. Moskowitz, M.D. Phyllis K. Murphy, M.D.

Michael A. Myers, M.D. Christopher G. Nelson, M.D. Barbro C. Nordqvist, M.D. Sandra L. Price, M.D. Bartholomew D. Ragucci, M.D. Blas A. Reyes, M.D. Daniel Rivlin, M.D. David A. Rodriguez, M.D. Michael J. Rogers, M.D. Susan S. Roper, M.D. Kenneth A. Rosen, M.D. Louis Rubin, M.D. David S. Sax, M.D. Justin L. Shields, M.D. Kristin W. Smallwood, M.D. Robert Snyder, M.D. Stephen A. Spencer, M.D. Roger H. Stewart, M.D. Charles W. Stiefel Werner K. Stiefel Michael J. Suah, M.D. Christopher Shea Virtue, M.D. Nelson A. Warner, M.D. Nardo Zaias, M.D.

GeorgiaChair James A. Yeckley, M.D.

Georgia—AtlantaChair Robert Swerlick, M.D. Vice Chairs Jack L. Arbiser, M.D., Ph.D. C. Russell Harris, Jr., M.D. Janice M. Warner, M.D. Jonathan S. Weiss, M.D.★

Julie E. Allee, M.D. Jordan H. Berne, M.D. Harold J. Brody, M.D. Stella M. Bulengo, M.D. S. Wright Caughman, M.D. Dan K. Chalker, M.D. Gregory J. Cox, M.D.Marian C. Finan, M.D. Robert M. Fine, M.D. John A. Fountain, M.D. William E. Freeman, M.D. Edmond I. Griffin, M.D. Mark J. Holzberg, M.D. William R. Howard, Jr., M.D. Billie L. Jackson, M.D. D. Scott Karempelis, M.D.E. Clyde Kelly III, M.D. Mark A. Knautz, M.D. Thomas J. Lawley, M.D. Jay A. Levin, M.D. David J. Levine, M.D. Calvin O. McCall, M.D. Paula Nelson, M.D. David B. Pharis, M.D. Frank J. Pinto, M.D. Bette C. Potter, M.D. Daniel C. Rabb, M.D.

Page 17: DERMATOLOGY

2003 ANNUAL REPORT 15

Orlando G. Rodman, Jr., M.D. Leslie F. Safer, M.D. James T. Sandwich, M.D. Michael J. Sharkey, M.D. George B. Skipworth, M.D. Sidney P. Smith III, M.D. Hiram M. Sturm, M.D. Stephen F. Templeton, M.D. Rebecca Y. Vaughn, M.D. Thomas R. Wade, M.D. Carl V. Washington, Jr, M.D. Wesley S. Wilborn, M.D. Isaac Willis, M.D. Keith D. Wright, M.D.

HawaiiChair Stella S. Matsuda, M.D.

Vice Chairs L. Bruce Mills, M.D. Sharon A. Minami, M.D., Ph.D.

Norman Goldstein, M.D. Timothy H. Hagino, M.D. Gregory Herbich, M.D. David M. Huntley, M.D. Julie R. Kenner, M.D. Kevin J. Mott, M.D. Carla J. Nip-Sakamoto, M.D. Robert S. Shapiro, M.D.

IdahoChair Kay Bishop, M.D.

C. Paul Brooke, M.D. Gerald G. Overly, M.D.◆ Carl R. Thornfeldt, M.D.

Illinois—NorthernChair Stephanie F. Marschall, M.D.

Vice Chairs Jeffrey S. Altman, M.D. Kenneth B. Bielinski, M.D. Jonith Y. Breadon, M.D. ★ Harry M. Goldin, M.D. Mark D. Hoffman, M.D. Arthur R. Rhodes, M.D., M.P.H.★

Illinois—SouthernChair Stephen P. Stone, M.D.

Vice Chairs Chester Danehower, Jr., M.D. Lester J. Fahrner, M.D.

Murad Alam, M.D. Arthur T. Altman, M.D. Thomas W. Andrews, M.D. John C. Ansel, M.D. Moira C. Ariano, M.D. Cheryl A. Armstrong, M.D. Iris Klawir Aronson, M.D. Bonnie Barsky, M.D. Gary J. Barsky, M.D.

Bruce Bennin, M.D. Mark A. Berk, M.D. Marshall L. Blankenship, M.D.◆ Wayne J. Blaszak, M.D. Amy L. Brodsky, M.D. Darryl M. Bronson, M.D. Clarence W. Brown, Jr., M.D. Jerome T. Budz, M.D. Michael Bukhalo, M.D. Robert A. Buzzell, M.D. Robert G. Carney, Jr., M.D. William A. Caro, M.D. I-Ja Chan, Ph.D. Rosemary Chen, M.D. Irving H. Distelheim, M.D. James O. Ertle, M.D. Matthew P. Evans, M.D. John H. Exner, M.D. David D. Fadness Jerome D. Fallon, M.D. Virginia C. Fiedler, M.D. Tony Sio-Ta Fu, M.D. Jerome M. Garden, M.D. Louisa Krusack Gehlmann, M.D. Jonathan N. Goldfarb, M.D. Kenneth B. Gordon, M.D. James F. Gregory, M.D. Joan Guitart, M.D. Shelley J. Halper, M.D. Matthew Harris, M.D. James J. Herrmann, M.D. Victoria L. Holloway, M.D. Sharon L. Horton, M.D. Carolyn I. Jacob, M.D. Ellen Jacobsen, M.D. Beth A. Jester, M.D. John B. Kalis, M.D. John T. Keane, M.D. Matthew R. Kelleher, M.D. Robert V. Kolbusz, M.D. Alan E. Lasser, M.D. Anne E. Laumann, MBChB, MRCP Ira Lawrence, M.D. Patricia A. Ledwig, M.D. Francis C. Lee, M.D. Tehming Liang, M.D., Ph.D. Susan Liebovitz, M.D. Frederick D. Malkinson, M.D. Eugene Mandrea, M.D. Mary C. Martini, M.D. Mary C. Massa, M.D. Alexandria Meccia, M.D. Jeffrey L. Melton, M.D. Julie A. Moore, M.D. Brian J. Nickoloff, M.D., Ph.D. Marianne N. O’Donoghue, M.D. Amy S. Paller, M.D. Edward S. Peterka, M.D. Kevin S. Pinski, M.D. Kathleen A. Remlinger, M.D. M. Joyce Rico, M.D. June K. Robinson, M.D. Marjorie Mintz Rosenbaum, M.D.Bryan C. Schultz, M.D.◆Christopher R. Shea, M.D.

Burton E. Silver, M.D. Albert H. Slepyan, M.D. Donna L. Stockton, M.D. Harry C. Stone II, M.D. Carol K. Tharp, M.D. Michael D. Tharp, M.D. David H. Whitney, M.D. Patricia P. Wyhinny, M.D. Scott Zahner, M.D. Charles Zugerman, M.D.

IndianaChair Peter L. Winters, M.D.

Vice Chair Charles W. Bartholome, M.D.

AnonymousGabriella Castillo, M.D. Gary P. Dillon, M.D. Alexander A. Fondak, M.D. C. William Hanke, M.D. Frederic P. Hibbeln, M.D. William C. Lentz, M.D. Robert E. McCallister, M.D. Thomas W. McGovern, M.D. M. Kathleen McTigue, M.D. Ginat W. Mirowski, D.M.D., M.D. Norma H. Schmitz, M.D. Keeter D. Sechrist, M.D. Linda V. Spencer, M.D. Barbara R. Sturm, M.D. Arthur J. Sumrall, M.D. Lori S. Swan, M.D.

IowaChair Richard D. Sontheimer, M.D. Vice Chairs John M. DeMay, M.D. Robert F. Godwin, M.D. Kent D. Walker, M.D. Susan D. Wall, M.D.

Richard T. Ameln, M.D. Andrew K. Bean, M.D. Roger I. Ceilley, M.D. Mark G. Cleveland, M.D., Ph.D. Bryon L. Gaul, M.D. Robert G. German, M.D. Steve Harlan, M.D. Allen D. Harves, M.D. J. William Holtze, M.D. Jennifer A. Palmer, M.D. Warren W. Piette, M.D. Gary E. Quinby, M.D., Ph.D. Kenzo Sato, M.D. Kimberly K. Schulz, M.D. Richard K. Scupham, M.D., Ph.D. Thorsteinn Skulason, M.D. Mary S. Stone, M.D. John S. Strauss, M.D. Marta J. Van Beek, M.D. John H. Wollner, M.D.

KansasChair Colleen M. Reisz, M.D.

Jonell Byers, M.D. Robert D. Durst, Jr, M.D. Michael D. Giessel, M.D. Michael L. Haag, M.D. Thelda M. Kestenbaum, M.D. Timothy T. Sawyer, M.D. Donald K. Tillman, Jr., D.O. Wallace N. Weber, M.D.

KentuckyChair Fernando R. DeCastro, M.D.

Teresa J. Bentley, M.D. Timothy S. Brown, M.D. Jyoti B. Burruss, M.D. Jeffrey P. Callen, M.D. William P. Davey, M.D. Vilma C. Fabre, M.D. Christopher J. Frost, M.D. Ronald D. Hall, M.D. Evelyn Montgomery Jones, M.D. Carol L. Kulp-Shorten, M.D. Shannon McAllister, M.D. Lafayette G. Owen, M.D. Jeffrey B. Richardson, M.D. Clifton Smith, M.D. George B. Sonnier, M.D. Robert H. Zax, M.D.

LouisianaChair Elizabeth I. McBurney, M.D. Vice Chairs Mary P. Lupo, M.D. ★ Richard N. Sherman, M.D.

Rhonda R. Baldone, M.D. Harris M. Blackman, M.D. Erin E. Boh, M.D., Ph.D. Harry A. Burglass, M.D.David J. Clemons, M.D. David Cooksey, M.D. Michael E. Cormier, M.D. John H. Counce, M.D. Patricia Farris, M.D. Wesley King Galen, M.D. Robert A. Koppel, M.D. Daniel A. Marshall, Jr., M.D. Larry E. Millikan, M.D. Lee T. Nesbitt, Jr., M.D. Donald I. Posner, M.D. H. Patrick Ragland, M.D. Marilyn C. Ray, M.D. Jack S. Resneck, M.D. Glenn G. Russo, M.D. Gordon J. Russo, M.D. Joseph P. Shrum, M.D. Nia Katechis Terezakis, M.D. John M. Yarborough, M.D.

Page 18: DERMATOLOGY

16 DERMATOLOGY FOUNDATION

MaineNancy Egan, M.D.

MarylandChair Stanley J. Miller, M.D. Vice Chairs Anthony A. Gaspari, M.D. Lisa J. Renfro, M.D. Daniel N. Sauder, M.D. David P. Smack, M.D.

Grant J. Anhalt, M.D. Robert S. Berger, M.D. Elizabeth M. Burke, M.D. Valerie D. Callender, M.D. Diane S. Ford, M.D. Ronald Goldner, M.D. Allan C. Harrington, M.D. Howard Hines, M.D. Robert Katz, M.D. Stephen I. Katz, M.D., Ph.D. Dennis Kurgansky, M.D. Stanford I. Lamberg, M.D. Gerald S. Lazarus, M.D. Barbara E. McAlpine, M.D. Sean L. McCagh, M.D.Mona Z. Mofid, M.D. Warwick L. Morison, M.D.Alan N. Moshell, M.D. Angela R. Peterman, M.D. Ronald B. Prussick, M.D. Kenrick H. Roberts, M.D. Howard N. Robinson, M.D. Tara A. Rumbarger, M.D. Luette S. Semmes, M.D. Albert Shapiro, M.D. ◆ David A. Spott, M.D. Mark C. Udey, M.D., Ph.D. Robert A. Weiss, M.D. Mark L. Welch, M.D.

MassachusettsChair Steven K. Shama, M.D. ◆ ★

Vice Chairs Thomas H. Cahn, M.D. Jeffrey S. Dover, M.D. Richard A. Johnson, M.D. Kay S. Kane, M.D. Jill R. Rosenthal, M.D.

A. Razzaque Ahmed, M.D. R. Rox Anderson, M.D. Kenneth A. Arndt, M.D. Howard P. Baden, M.D. Jag Bhawan, M.D. Paul S. Birnbaum, M.D. Nina C. Blumenthal, M.D. Nydia Del R. Camacho- Padilla, M.D. Marilyn R. Capek, M.D. Lisa M. Cohen, M.D. Thomas W. Cooper, M.D. Dorothy J. Cunningham, M.D. Glenn A. Dobecki, M.D.

Jessica L. Fewkes, M.D. Barbara A. Gilchrest, M.D. Ernesto Gonzalez, M.D. Samuel D. Goos, M.D. Donald J. Grande, M.D. Terry P. Hadley, M.D. Christine M. Hayes, M.D. Harley A. Haynes, M.D. Ranella J. Hirsch, M.D. Shang I. Brian Jiang, M.D. Steven M. Kahn, M.D. Michael S. Kaminer, M.D. Seth G. Kates, M.D. Amy B. Koff, M.D. Nellie Konnikov, M.D. James V. Kowalski, M.D. George Kroumpouzos, M.D., Ph.D. Thomas Kupper, M.D. Joseph C. Kvedar, M.D. Lisa H. Lerner, M.D. Mark A. Liska, M.D. Merrill G. Liteplo, M.D. Claire P. Mansur, M.D. Martin C. Mihm, Jr., M.D. John A. Parrish, M.D. Barry S. Paul, M.D. Michael M. Pugliese, M.D. Francis S. Renna, M.D. Andrew D. Samel, M.D. Steven J. Ugent, M.D. Stephen G. Werth, M.D. Donna M. Yonkosky, M.D., Ph.D.

MichiganChair Henry W. Lim, M.D. Vice Chairs Sewon Kang, M.D. ★ Darius R. Mehregan, M.D. ★ Ali Moiin, M.D. George J. Murakawa, M.D. Earl J. Rudner, M.D. John R. Vydareny, M.D. ★ Kay E. Watnick, M.D.

David A. Altman, M.D. Mary Beth Anderson, D.O. Thomas F. Anderson, M.D.AnonymousPeter J. Aronson, M.D. Richard J. Ashack, M.D. Barry I. Auster, M.D. David A. Baird, M.D. David S. Balle, M.D. Mark R. Balle, M.D. Walter Barkey, M.D. Alan R. Berlin, D.O. Henry G. Bryan, M.D. David R. Byrd, M.D. Roger C. Byrd, D.O. Amy B. Cardellio, D.O. Albert C. Cattell, M.D. Johanna Chapel, M.D. Neldagae S. Chisa, M.D. Cynthia Tseng Chow, M.D. Jenny Cotton, M.D., Ph.D.

Lawrence J. Desjarlais, M.D. Andrzej A. Dlugosz, M.D. Helene C. Dombrowski, M.D. Thomas F. Downham II, M.D. Howard V. Dubin, M.D. James T. Elder, M.D., Ph.D. Charles N. Ellis, M.D. Lori Marcum Fedoronko, M.D. Kevin J. Gaffney, M.D. Brian J. Gerondale, M.D. Michael T. Goldfarb, M.D. Steven K. Grekin, D.O. Joan M. Griner, M.D. Iltefat H. Hamzavi, M.D. Thomas D. Harris, M.D. Karen A. Heidelberg, M.D. Ann E. Hern, M.D. Jean M. Holland, M.D. Timothy M. Johnson, M.D. Darius J. Karimipour, M.D. Scott B. Karlene, M.D. Robert J. Lamberts, M.D. Robert G. Lee, M.D. Won K. Lee, M.D. Lori Lowe, M.D. Jolanta E. Malinowski, M.D. Lisa A. Manz-Dulac, M.D. David A. Mehregan, M.D. Andrew L. Messenger, M.D. Gregory G. Messenger, M.D. Jeffrey L. Messenger, M.D. John E. Miner, M.D. Andrew J. Mitchell, M.D. Jeffrey S. Orringer, M.D. Dipa S. Patel, M.D. Michael J. Redmond, M.D. Mitchell A. Rinek, M.D. Robert J. Schoenfeld, M.D. Jennifer L. Schwartz, M.D. Steven Shumer, M.D. Marvin D. Siegel, M.D. Michael T. Siegel, M.D. Kimball W. Silverton, D.O. Milton D. Soderberg, M.D. Robert M. Soderstrom, M.D. David V. Spurlin, M.D. Marek A. Stawiski, M.D. Daniel M. Stewart, D.O. Stephen W. Sturman, M.D. John J. Voorhees, M.D. ★ Timothy S. Wang, M.D. Howard G. Welgus, M.D.

MinnesotaChair Natalie S. Roholt, M.D.

Bruce J. Bart, M.D. Charles H. Dicken, M.D. Daniel K. Elieff, M.D. Frederick S. Fish III, M.D. Lynn A. Benson Glesne, M.D. Ngo Thanh Hien, M.D. Maria K. Hordinsky, M.D. Valda N. Kaye, M.D. Roy S. Rogers III, M.D.

Arnold L. Schroeter, M.D. Al Sheldon Zelickson, M.D. Brian D. Zelickson, M.D.

MississippiC. Ralph Daniel, M.D. William H. Gullung III, M.D. Jeffrey C. Houin, Jr., M.D.

MissouriChair Peter J. Muelleman, M.D. Vice Chair Victoria Gunn, M.D.

Susan K. Ailor, M.D. Jennifer D. Ashby, M.D. Lynn A. Cornelius, M.D. John D. DeSpain, M.D. Gary A. Dyer, M.D. Karen E. Edison, M.D. Arthur Z. Eisen, M.D. Jacquelyn B. Garrett, M.D. John C. Hall, M.D. Mark A. Hurt, M.D. Madhavi Kandula, M.D. Craig L. Leonardi, M.D. Sharon G. McDonald, M.D. David E. Payne, M.D. Lindall A. Perry, M.D. David C. Rada, M.D.

MontanaChair Juliana Hicks, M.D.

Jeffry A. Goldes, M.D. Gail A. Kleman, M.D. E. David Wright, M.D.

NebraskaChair Rodney S.W. Basler, M.D. ◆★ Vice Chair Geoffrey C. Basler, M.D.

Brent Behrens, PA-C John J. Ferguson, M.D. Bert C. Frichot III, M.D. Christopher J. Huerter, M.D. David N. Kingsley, M.D. John R. Luckasen, M.D. Kerri Otto, PA-C David J. Watts, M.D.

NevadaChair Curt P. Samlaska, M.D.

New HampshireDaniel W. Collison, M.D. F. William Danby, M.D. E. William Frank, M.D. Sidney N. Klaus, M.D. Kathryn A. Zug, M.D.

Page 19: DERMATOLOGY

2003 ANNUAL REPORT 17

New Jersey—NorthChair Cheryl D. Ackerman, M.D.

New Jersey—SouthChair

Eric F. Bernstein, M.D.

Beatrice Bland Abrams, Ph.D. Jerry Bagel, M.D. Saida Baxt, M.D. Bruce J. Berger, M.D. Susan Bershad, M.D.◆ Jay E. Birnbaum, Ph.D. Gregory M. Borsuk, M.D. Douglas Canfield Meghan M.S. Caruso, D.O.Coyle S. Connolly, D.O. William F. Cosulich, M.D. Booth H. Durham, M.D. Herbert S. Feinberg, M.D. Rami E. Geffner, M.D. David J. Goldberg, M.D. Ira H. Gouterman, M.D. Daniel S. Groisser, M.D. Melvin S. Gruber, M.D.Warren R. Heymann, M.D. William D. Ju, M.D. Lincoln Krochmal, M.D. Emanuel G. Kuflik, M.D. David G. Lewis, M.D. Albert L. Rosenthal, M.D. Kurt S. Stenn, M.D. James T. Vail, Jr., M.D.

New MexicoJames H. Auerbach, M.D. Joel R. Barkoff, M.D.

New York—DownstateChair Richard K. Scher, M.D. ◆★

Vice Chairs David J. Arluk, M.D. Hilary E. Baldwin, M.D. Ronald R. Brancaccio, M.D. ★ Lance H. Brown, M.D. Richard D. Granstein, M.D. Neil S. Sadick, M.D.

New York—UpstateChair Walter S. Brooks, M.D.

Vice Chairs Michael Bobrow, M.D. Marc D. Brown, M.D. Kevin B. Kulick, M.D.

Dale M. Abadir, M.D. A. Bernard Ackerman, M.D. Douglas D. Altchek, M.D.Anonymous Jay G. Barnett, M.D. Vincent S. Beltrani, M.D. Diane S. Berson, M.D.

David R. Bickers, M.D. ◆ David E. Biro, M.D. Gary J. Brauner, M.D.Karen E. Burke, M.D., Ph.D. Penina Burnstein, M.D. Julide Tok Celebi, M.D.Richard A. Clark, M.D Steven R. Cohen, M.D., M.P.H. Patrick J. Condry, M.D. Michael J. Dannenberg, M.D.Vincent A. DeLeo, M.D. Jack Eisert, M.D. Michael Fisher, M.D. Helen Flamenbaum, M.D. Raul Fleischmajer, M.D. Paul J. Frank, M.D. David F. Frankel, M.D. Irwin M. Freedberg, M.D. Robert J. Friedman, M.D. Maria C. Garzon, M.D. Ellen C. Gendler, M.D. Roy G. Geronemus, M.D. Herbert P. Goodheart, M.D. Lillian R. Graf, M.D. Alan J. Halperin, M.D. N. Patrick Hennessey, M.D. Ann C. Hill, M.D. Francis W. Iacobellis, M.D. Marie-Louise Johnson, M.D., Ph.D.Richard S. Kalish, M.D., Ph.D. Hideko Kamino, M.D. Paul Kechijian, M.D. Jeffrey S. Kezis, M.D. Lester Klein, M.D.Mitchell A. Kline, M.D. Mark Lebwohl, M.D. Albert M. Lefkovits, M.D. Donald L. Levin, M.D. Lawrence M. Lieblich, M.D. Peter C. Lombardo, M.D. Cynthia A. Loomis, M.D., Ph.D. Timothy D. Mattison, M.D. Thomas O. McMeekin, M.D. Mary G. Mercurio, M.D. Craig C. Miller, M.D. Jan E. Muhlbauer, M.D. Rhoda S. Narins, M.D. Richard B. Narins, M.D. Kishwer S. Nehal, M.D. Antoinette P. Notaro, M.D. Norman Orentreich, M.D.Allan R. Oseroff, M.D., Ph.D. Ariel Ostad, M.D. Virginia Fallon Pellicci, M.D. Alice P. Pentland, M.D. Robert G. Phelps, M.D. Stephanie H. Pincus, M.D., M.B.A. Ross B. Pollack, M.D. Desiree Ratner, M.D. Michael L. Reed, M.D. Dana L. Sachs, M.D. Stacy P. Salob, M.D. Glynis A. Scott, M.D. Alan R. Shalita, M.D.◆ Jerome L. Shupack, M.D.

Daniel M. Siegel, M.D. David N. Silvers, M.D. Lynn Silverstein, M.D. Robert A. Skrokov, M.D. Nicholas A. Soter, M.D. Joel L. Spitz, M.D. Marcia G. Tonnesen, M.D. John H. Tu, M.D. Donald S. Waldorf, M.D. ◆ Heidi A. Waldorf, M.D. Robert R. Walther, M.D. Patricia S. Wexler, M.D. Michael B. Whitlow, M.D., Ph.D. Daniel B. Yarosh, Ph.D. Eugene G. Zappi, M.D. Murray Zung, M.D.

North CarolinaChair J. Blake Goslen III, M.D. ★

Vice Chairs Alexander Chiaramonti, M.D. ★ Gloria F. Graham, M.D. Frederick A. Lupton, M.D.★ W. Harrison Turner III, M.D.

Robert A. Briggaman, M.D.Charles J. Brown, M.D. Marc R. Carruth, M.D. Robert E. Clark, M.D., Ph.D. Gerald E. Cooley, M.D. Mary L. Courrege, M.D. George W. Crane, Jr., M.D. Luis A. Diaz, M.D. Zoe D. Draelos, M.D. Steven R. Feldman, M.D., Ph.D. Donald D. Fraser, M.D. Walter R. Gammon, M.D. Ronald L. Godbold, M.D. Lowell A. Goldsmith, M.D. James H. Graham, M.D. Russell P. Hall, III M.D. Frank M. Houston, M.D. Joseph L. Jorizzo, M.D. William S. Ketcham, M.D. Barry Leshin, M.D. Debra C. Liu, M.D. John C. Murray, M.D. Adnan Nasir, M.D., Ph.D. Elise Olsen, M.D. Lawrence H. Pearson, M.D. Sheldon R. Pinnell, M.D. Elisa M. Roberts, M.D. Kerry M. Shafran, M.D. Cameron L. Smith, M.D. Stuart Tafeen, M.D. John A. Thompson, Jr, M.D. John R. Van Gurp, M.D., Ph.D. Clayton E. Wheeler, Jr., M.D.

North DakotaChair Richard W. Blaine, M.D.

Ohio—NorthernChair Jonathan Bass, M.D.

Vice Chairs Anita C. Gilliam, M.D., Ph.D. Gary D. Lichten, M.D. William S. Lynch, M.D. Eliot N. Mostow, M.D. ★ Stephen C. Somach, M.D.

Ohio—SouthernChair Hugh M. Gloster, Jr., M.D.

Vice Chairs Diya F. Mutasim, M.D. Julian J. Trevino, M.D.

John P. Anders, M.D. Jaye E. Benjamin, M.D. Brian P. Biernat, M.D. Robert T. Brodell, M.D. ◆ Brett M. Coldiron, M.D. Kevin D. Cooper, M.D. Renuka Diwan, M.D. Heidi B. Donnelly, M.D. William Dorner, Jr, M.D. H. Michael Duke, M.D. R. Bennett Eppes, M.D. James W. Finn, M.D. Z. Charles Fixler, M.D. Monte E. Fox, D.O. Mahmoud A. Ghannoum, Ph.D. Scott C. Grevey, M.D. Curtis W. Hawkins, M.D. Stephen E. Helms, M.D. Cynthia Paradies Huang, M.D. Michelle A. Jahnke, M.D. Christine Jaworsky, M.D. Jay C. Klemme, M.D. Neil J. Korman, M.D., Ph.D. George H. Kuffner, M.D. Stephen B. Levitt, M.D. Lian-Jie Li, M.D. Jenifer R. Lloyd, D.O. Michael G. Mancuso, M.D. Robert E. Marsico, Jr., M.D. Robert E. Marsico, Sr., M.D. Beno Michel, M.D. John C. Moad, M.D. Susan T. Nedorost, M.D. Thomas G. Olsen, M.D. Jerome R. Pomeranz, M.D. Jennifer M. Ridge, M.D. Omar S. Salem, M.D. Donald R. Schermer, M.D. Patrick L. Shannon, M.D. Guillermo R. Sicard, M.D. Willard D. Steck, M.D. Helen M. Torok, M.D. Allison T. Vidimos, M.D. Schield M. Wikas, D.O. Marlene D. Willen, M.D.

Page 20: DERMATOLOGY

18 DERMATOLOGY FOUNDATION

OklahomaChair David M. Adelson, M.D.

David K. Eslicker, D.O. Lawrence J. Gregg, M.D.Scott W. Meyers, M.D. James B. Stewart, Jr., M.D. Douglas M. Vaughn, D.O.

OregonChair Richard E. Otoski, M.D. Vice Chair

Douglas N. Naversen, M.D.

Michael J. Adler, M.D.Anonymous Diane R. Baker, M.D. Brooks G. Cofield, D.O. Scott A. B. Collins, M.D. Jon M. Hanifin, M.D. Frederick A.J. Kingery, M.D. Marla M. Klein, M.D. Walter G. Larsen, M.D. Ken K. Lee, M.D. Edgar Maeyens, Jr., M.D. Robert T. Matheson, M.D. Phoebe Rich, M.D. Julee K. Richards, M.D. Janet L. Roberts, M.D. Marla Ross, M.D. Theresa L. Schroeder, M.D. Neil A. Swanson, M.D. Bert G. Tavelli, M.D. Dwight R. Tribelhorn, M.D. Douglas K. Zirker, M.D.

Pennsylvania—EasternChair Stuart R. Lessin, M.D.

Vice Chairs Bruce A. Brod, M.D. Scott L. Gottlieb, M.D. ★ O. Fred Miller III, M.D. ★ Franziska Ringpfeil, M.D. Diane M. Thiboutot, M.D. Victoria P. Werth, M.D. Joseph A. Witkowski, M.D. Jonathan T. Wolfe, M.D.

Pennsylvania—WesternChair Orin M. Goldblum, M.D. Vice Chairs Nancy S. House, M.D. Douglas W. Kress, M.D.

Edward Abell, M.D. Donald J. Adler, D.O. David A. Amato, D.O. Arthur K. Balin, M.D., Ph.D. John O. Barton, M.D. Joseph B. Bikowski, M.D. Elizabeth M. Billingsley, M.D. Steven A. Binnick, M.D.

Dominic A. Brandy, M.D. J.B. Braun, M.D. David G. Brodland, M.D. Guy J. Carnabuci, M.D. Rebecca J. Caserio, M.D. Donald R. D’Annunzio, M.D. Jau-Shyong Deng, M.D.Louis D. Falo, Jr., M.D. Rosalie Elenitsas, M.D. Patrick R. Feehan, M.D.Richard G. Fried, M.D., Ph.D. Loren S. Funt, M.D.Herbert Goldschmidt, M.D. Charles H. Greenbaum, M.D. Thomas D. Griffin, M.D. Gary Grove, Ph.D. Mark H. Hassel, M.D. Nathan R. Howe, M.D., Ph.D. Sharon L. Hrabovsky, M.D. William D. James, M.D. Bernett L. Johnson, M.D. Waine C. Johnson, M.D. Jacqueline M. Junkins- Hopkins, M.D. Kays H. Kaidbey, M.D. Albert M. Kligman, M.D.◆ Caroline S. Koblenzer, M.D. E. Michael Kramer, M.D. Herbert M. Leavitt, M.D. Stanton S. Lebouitz, M.D. Jason B. Lee, M.D. James J. Leyden, M.D. ◆ Paul R. Long, M.D. Stephanie A. Mackey, M.D. James G. Marks, Jr., M.D. Victor J. Marks, M.D. Michele S. Maroon, M.D. Barbara M. Mathes, M.D. Michael E. Ming, M.D. Suzan Obagi, M.D. Steven K. Orman, M.D. Lawrence C. Parish, M.D. Herbert M. Parnes, M.D. Michael L. Ramsey, M.D. Daniel Roling, M.D. Alain H. Rook, M.D. Robert L. Roschel, M.D. Rudolf R. Roth, M.D. Paul J. Ruschak, M.D. Michael Saruk, M.D. Mark P. Seraly, M.D. Douglas L. Sheldon, M.D. William K. Sherwin, M.D. Alan R. Silverman, M.D. Shobana Sood, M.D. Richard L. Spielvogel, M.D. John R. Stanley, M.D. Lawrence M. Stokar, M.D. John G. Stoner, M.D. Jouni J. Uitto, M.D., Ph.D.◆ Eugene J. Van Scott, M.D.◆ David B. Vasily, M.D. Guy F. Webster, M.D., Ph.D. Ruey J. Yu, Ph.D., O.M.D. ◆

Rhode IslandNomate Kpea, D.O. Leslie Robinson-Bostom, M.D.

South CarolinaChair Linwood G. Bradford, M.D.

John M. Brewer, M.D. A. Thomas Bundy, M.D. Jim C. Chow, M.D. Pierre Jaffe, M.D. Carl A. Johnson, M.D. Lawrence Klein, M.D. Phillip L. Latham, Jr., M.D. John C. Maize, M.D. Oswald L. Mikell, M.D. Ben M. Treen, M.D. ◆

South DakotaChair James R. McGrann, M.D.

TennesseeChair George P. Stricklin, M.D., Ph.D.

Vice Chairs Michael W. Bell, M.D. John Q. Binhlam, M.D. Lawrence L. Bushkell, M.D. ★

Rex A. Amonette, M.D. ◆ Donald E. Clemons, M.D. T. Wayne Day, M.D. Dan A. Dunaway, M.D. Darrel L. Ellis, M.D. Melvin L. Elson, M.D. ◆ James P. Fields, M.D. Charles S. Fulk, M.D. J. Harvey Gardner, M.D. Michael H. Gold, M.D. Paul Googe, M.D. Don C. Harting, M.D. Charles I. Huddleston, M.D. Larry D. Hudson, M.D. Clark E. Julius, M.D. Lloyd E. King, Jr, M.D., Ph.D. Dana L. Latour, M.D. Jami L. Miller, M.D. Lucien C. Simpson, M.D. Thomas Stasko, M.D. James E. Turner, M.D., Ph.D. George B. Winton, M.D. Michael D. Zanolli, M.D.

Texas—DallasChair Lisa A. Garner, M.D. ★ Vice Chairs Christine D. Brown, M.D. Philip W. Giles, M.D. M. Gayle Mullanax, M.D. Dennis E. Newton III, M.D.

Texas—EasternChair Phillip B. Bandel, M.D. Vice Chairs Lawrence L. Anderson, M.D. T. Lynn Warthan, M.D.

Texas—HoustonChair Ronald P. Rapini, M.D. Vice Chairs Jimmy D. Schmidt, M.D. ◆★ Jaime A. Tschen, M.D. Stephen K. Tyring, M.D., Ph.D.

Texas—San Antonio/AustinChair Charles S. Thurston, M.D. Vice Chairs Stephen D. Houston, M.D. ★ Jeffrey J. Meffert, M.D. Gregory W. Thompson, M.D.

William Abramovits, M.D. Daniel S. Achtman, M.D. Mary Zieglschmid Adams, M.D. Max F. Adler, M.D. Ross A. Alexander, M.D. Myra O. Barker, Ph.D. Matthew D. Barrows, M.D. Paul R. Bergstresser, M.D. Stephen L. Blum, M.D. James R. Bond, Jr., M.D. Michael W. Braden, M.D. Forrest C. Brown, M.D. Stuart M. Brown, M.D. Suzanne Bruce, M.D. Turner M. Caldwell III, M.D. Fred F. Castrow II, M.D. Jennifer Clay Cather, M.D. Robert L. Chappell, Jr., M.D. Debra L. Chernosky, M.D. Marvin E. Chernosky, M.D. ◆ Justin W. Clark, M.D. Stephen W. Clark Clay J. Cockerell, M.D. Jack B. Cohen, D.O.Maria I. Colome-Grimmer, M.D. William F. Cothern, D.O. Michael H. Coverman, M.D. Ponciano D. Cruz, Jr, M.D. Ronald S. Davis, M.D. Thomas L. Davis, M.D. Elizabeth Dolan, M.D. Susan E. Dozier, M.D. Janet C. DuBois, M.D. Madeleine Duvic, M.D. Anne Epstein, M.D. Rebecca L. Euwer, M.D. Wayne A. Fagan, M.D. R. John Fox, Jr., M.D. Toni Funicella, M.D. John J. Ghidoni, M.D. Irma Gigli, M.D. Leonard H. Goldberg, M.D.

Page 21: DERMATOLOGY

2003 ANNUAL REPORT 19

William J. Grabski, M.D. Brad S. Graham, M.D. Ronald E. Grimwood, M.D. Adelaide A. Hebert, M.D.Beverly L. Held, M.D. James H. Herndon, Jr., M.D. Peter D. Hino, M.D. Edmund R. Hobbs, M.D. Richard H. Hope, M.D. Karen R. Houpt, M.D. F. Lester Howsden, M.D. Susan M. Howsden, M.D. Sylvia Hsu, M.D. Mary E. Hurley, M.D. Coleman Jacobson, M.D. ◆ Robert E. Jordon, M.D. Aaron K. Joseph, M.D. Lawrence M. Joseph, M.D. Candace S. Kasper, M.D. Charles D. Kennard, M.D. Mark D. Koone, M.D. Byron L. Limmer, M.D. Rachel L. Limmer, M.D. James D. Maberry, M.D. Stephen D. Maberry, M.D. David D. Madorsky, M.D. Michael L. Maris, M.D. Christie E. Matter-Baranski, M.D. Martha L. McCollough, M.D. Alan Menter, M.D. ◆ D. Scott Miller, M.D. Angela Yen Moore, M.D. Tho Q. Nguyen, M.D. Jeffrey M. Niemann, M.D. Jackie L. Nixon-Fulton, M.D. Amit G. Pandya, M.D. William T. Parsons, M.D. ◆ Steven D. Pedro, M.D. Alden Pinnell Susana C. Poliak, M.D. Mark A. Price, M.D. William M. Ramsdell, M.D. Mark K. Ray, M.D. Ronald J. Ressmann, M.D. Joe B. Richardson, M.D. Robin A. Roberts, M.D. Carl B. Rountree, M.D. Richard N. Rudnicki, D.O. Lilly H. Schaffer, M.D. Shelley Sekula-Gibbs, M.D. Edward M. Shapiro, M.D. Jerald L. Sklar, M.D. Roy E. Spencer, M.D. Cloyce L. Stetson, M.D. Charles S. Stevens, M.D. Allison J. Stocker, M.D. R. Stan Taylor, M.D. Craig F. Teller, M.D. Mark D. Thieberg, M.D. Bryan L. Townsend, M.D. Gary L. Upton, M.D. Premalatha Vindhya, M.D. Patrick Walsh, M.D. Bill V. Way, D.O. David A. Whiting, M.D.

Daniel D. Witheiler, M.D. John E. Wolf, Jr, M.D. Jeffrey P. Young, M.D.

UtahChair Leonard J. Swinyer, M.D. Vice Chairs John L. Bezzant, M.D. R. Ralph Bradley, M.D. C. David Hansen, M.D. Gerald G. Krueger, M.D. Wendy L. Matis, M.D.

John S. Blake, M.D. Anneli R. Bowen, M.D. Glen M. Bowen, M.D. Russell W. Eyre, M.D. Warren G. Eyre, M.D. Scott R. Florell, M.D. Douglas Grossman, M.D., Ph.D. Kraig K. Jenson, M.D. Sancy A. Leachman, M.D., Ph.D. Laurence J. Meyer, M.D., Ph.D. Robert L. Orme, M.D. Marta J. Petersen, M.D. Douglas L. Powell, M.D. Bernard J. Simbari, M.D. Wallace B. Smith, M.D. Wayne E. Smith, M.D. Bradley K. Summers, M.D. Mark B. Taylor, M.D. Stephen T. Thomson, M.D. Justin F. Thulin, M.D. Sheryll L. Vanderhooft, M.D. John J. Zone, M.D.

VermontChair Paul A. Krusinski, M.D.

Alan N. Binnick, M.D. W. Landon Dennison, Jr., M.D.

VirginiaChair William S. Sawchuk, M.D. Vice Chair Evan R. Farmer, M.D.

Lawrence Kuo Chang, M.D. Herbert S. Golomb, M.D. George W. Hambrick, Jr., M.D. Martin S. Horn, M.D. Hazle Smith Konerding, M.D. Paul H. Kravitz, M.D. Russell H. Mitchell, M.D. Andrew D. Montemarano, D.O. David M. Pariser, M.D. Jerome M. Parsons, M.D. Charles F. Payne, Jr., M.D. Steven M. Rotter, M.D. Robert Silverman, M.D. Katherine A. Treherne, M.D. Charles B. Weber, D.O.

WashingtonChair James L. Brazil, M.D.

Paul W. Becker, M.D. Craig S. Birkby, M.D. Joel H. Datloff, M.D. Richard S. Herdener, M.D. Brandith Irwin, M.D. Peter B. Odland, M.D. John E. Olerud, M.D. James H. Petrin, M.D. Joel K. Sears, M.D. Karen M. Vigeland, M.D. W. Phillip Werschler, M.D. Dan A. Wiklund, M.D.

West VirginiaChair Alan M. Ruben, M.D.

WisconsinChair Janet A. Fairley, M.D. Vice Chairs Donald J. Miech, M.D. ★ Marcy Neuburg, M.D. Gary S. Wood, M.D.

Eric R. Berg, M.D. John S. Cantieri, M.D. David L. Crosby, M.D. Beth A. Drolet, M.D. Nancy Burton Esterly, M.D. Kenneth H. Katz, M.D. Edward L. Knuteson, M.D. Paul O. Larson, M.D. Robert A. McDonald, M.D. Eugene W. Monroe, M.D. Tara L. Passow, M.D. Thomas J. Russell, M.D. Lawrence C. Scherrer, M.D., Ph.D. Michael J. Smullen, M.D. Stephen N. Snow, M.D. Glenn E. Sondag, M.D. Kathleen S. Stokes, M.D. Erik J. Stratman, M.D. James L. Troy, M.D. David Wacker, M.D. Stephen B. Webster, M.D. Barbara Dahl Wilson, M.D. Kim B. Yancey, M.D.

WyomingChair Scott D. Bennion, M.D.

Thomas J. Hogarty, M.D. Larry E. Seitz, M.D. Sandra K. Surbrugg, M.D.

Rowan E. Tichenor, M.D.

AUSTRIAErwin Tschachler, M.D.

CANADAAlastair Carruthers, M.D.

Walter P. Unger, M.D.

JAPANTakashi Aoyagi, M.D.

KEY

◆ Annenberg Circle Founder

Annenberg Circle Member

★ Enrolled Three or More Leaders Society Members

Leaders Society Founding & Continuous Member

Page 22: DERMATOLOGY

20 DERMATOLOGY FOUNDATION

Identification of Outcome Predictors in Juvenile Localized SclerodermaScleroderma is a connective tissue disease characterized by excess collagen deposition and fibrosis, primarily involving the skin and subcutaneous tissues but also affecting other organ systems. A subtype of this condition, called localized scleroderma, is more common in children and can have devastating effects on growth and development. Very little epidemiologic data exists on juvenile localized scleroderma. Our study will investigate which factors are predictive of improved/poorer outcomes in juvenile localized scleroderma.

Amy Gilliam, M.D.

University of California, San Francisco

04Fellowship in Pediatric Dermatology

04Research Fellowships

Transcriptional Regulation of Skin and Hair DevelopmentNormal skin formation requires a balance between growth and development. One group ofproteins that may participate in these processes is the AP-2 family of proteins. AP-2 proteins areexpressed throughout the skin, and some are expressed abnormally in certain cancers, includingsome skin cancers. I will investigate how AP-2 proteins control the normal development of skinand hair, which may suggest how these proteins contribute to the development of cancer.

David H. Chu, M.D., Ph.D.

Rockefeller University

The Role of EphA2 in Melanoma Progression and MetastasisMalignant melanoma is a life threatening skin cancer. Melanoma often originates in common moles and progresses through various stages of invasive cancer and ultimately may spread to distant organs (metastasis). Eph cell surface receptors are not present in normal melanocytes and moles, but have been shown to increase during the transition from normal mole to invasive melanoma. We are investigating the role of the EphA2 receptor in the progression and spread of melanoma.

Bradley K. Draper, M.D., Ph.D.

Vanderbilt University

The Relationship of Demographic, Geographic, and Socioeconomic Factors in Melanoma Prognosis: An Examination of Melanoma Mortality in SEER RegistriesThis study will use Geographic Information Systems (GIS), a computer program which generates digital maps, to create maps of melanoma prognosis using a national cancer registry. It is hoped that these maps, which will include information such as median poverty level, education, and the number of dermatologists in the community, can help to explain differences in melanoma outcomes in different groups of people, including racial and ethnic groups that have worse melanoma survival outcomes.

Melody J.Eide, M.D.

Brown University

The Dermatology Foundation and the Society for Pediatric Dermatology partner in funding clinical fellowships in

pediatric dermatology. This one-year award, which provides $45,000 in salary stipend, will foster the development of

clinical scholars in pediatric dermatology to advance the field in patient care, research and teaching.

This category of support, which provides a $30,000 salary stipend for one year, focuses on providing training in research

skills relevant to dermatology and cutaneous biology.

Page 23: DERMATOLOGY

2003 ANNUAL REPORT 21

Role of a Pattern Recognition Receptor, Human Dectin-2, in Th2-polarizationWe have discovered the dectin-2 receptor expressed in mice by Langerhans cells and dendritic cells. This receptor recognizes house dust mite allergen and the hyphae (but not yeast) form of fungi. Binding of dectin-2 to house dust mite allergen and hyphae leads dendritic cells to produce IL-4, a cytokine associated with Th2-mediated diseases. Most recently we discovered the human equivalent of mouse dectin-2, whose properties are the subject of this study. Our findings may lead to development of drugs that target dectin-2 in order to enhance or block IL-4 production. We also plan to study a possible relationship between dectin-2 and Th2 diseases such as atopic dermatitis and allergic asthma and rhinitis.

Alde C. Patdu Gavino, M.D.

University of Texas, Southwestern Medical Center

Role of ID Proteins in Hair Follicle and Epithelial Stem Cell BiologyEpithelial stem cells in the hair follicle bulge are important for hair follicle growth and skin cancer formation. We have defined several candidate genes that may be responsible for controlling the behavior and growth of these cells. We will study whether the family of genes known as “ID, inhibitor of differentiation” genes affect hair growth and skin cancer formation in genetically engineered mice.

Mayumi Ito, Ph.D.

University of Pennsylvania School of Medicine

A Randomized, Split-Face Comparison of the Treatment of Facial Angio-fibromas in Tuberous Sclerosis Utilizing a 532nm Frequency-doubled Nd: YAG (KTP) Laser, a585nm Pulsed-dye Laser with a 40ms Pulse Duration, and a 585nm Pulsed-dye Laser with a 0.5 Pulse

04Patient Directed Investigation Grant

Joanna Burch, M.D.University of Colorado, Denver

The BRAF Gene as a Genetic Marker in Distinguishing Spitz Nevi from Melanoma Julide Tok Celebi, M.D.Columbia University

Prenatal Risk Factors for Hemangiomas of InfancyBeth A. Drolet, M.D.Medical College of Wisconsin

Efficacy of Oral Tazorotene as a Chemopreventive Agent Against Non-Melanoma Skin Cancer in Solid Organ Transplant Recipients, a Randomized, Double-Blind,Placebo-Controlled Trial

Fiona M. O’Reilly, M.D.Emory University

Clinical Significance of BRAF Mutation in Melanoma David Polsky, M.D., Ph.D.New York University

The following Grants provide $20,000 over one year in support for medical and surgical dermatology and cutaneous

biology that have the potential to directly benefit patients and the dermatology community-at-large. The Ichthyosis

and Dermatopathology Grants are funded through the partnership of the DF with the Foundation for Ichthyosis and

Related Skin Types (F.I.R.S.T.) and the American Society of Dermatopathology, respectively.

Page 24: DERMATOLOGY

22 DERMATOLOGY FOUNDATION

Anna Lee Bruckner, M.D.University of California, San Francisco

Utility of Ultrastructure in the Diagnosis of Ichthyosis

Testing Gene Therapy Approaches for Epidermolytic Hyperkeratosis Jiang Chen, M.D.Baylor College of Medicine

Pleiotrophin in Melanoma Tumor Progression and Melanocyte DevelopmentHong Wu, M.D., Ph.D.Temple University

Residency Commencement Infrastructure Development at the Marshfield Clinic Department of Dermatology

Erik J. Stratman, M.D.Marshfield Clinic

The CYLD Protein and its Role in Cutaneous Biology Julide Tok Celebi, M.D.Columbia University

Generation and Analysis of Langerhans Cell Deficient Mice Daniel H. Kaplan, M.D., Ph.D.Yale University

Elucidation of the Role of the Melanocortin 1 Receptor Gene as a Melanoma Susceptibility Gene

Sancy A. Leachman, M.D., Ph.D.University of Utah

Melanocyte Response to Chemotoxins: Implications for Understanding and Treating Vitiligo and Melanoma

Prashiela Manga, Ph.D.University of Cincinnati

CYR61: Novel Regulator of Matrix Metalloproteinase-mediated Age-RelatedDestruction of Human Skin

Taihao Quan, Ph.D.University of Michigan

The Role of Ganglioside in uPA/uPAR-Modulated Signaling Xiao-Qi Wang, M.D., Ph.D.Children’s Memorial Hospital

04Ichthyosis Research Grant

04Dermatopathology Research Grant

04Program Development Grant

04Research Grant

This unique $10,000, one-year grant supports the development of scientific infrastructure in a department or

division of dermatology that has not successfully competed for DF funding.

Page 25: DERMATOLOGY

Research Award Application Procedurespathologists who have recently completed a Dermatopathology fellowship in a division or department of dermatology, pathology or Dermatopathology and who are attempting to embark on research careers. Program Development Awards provide $10,000 for one year to support development of scientific infrastructure in those dermatology departments/divisions that are accredited residency training centers but have not successfully competed for Dermatology Foundation support during the most recent five-year period.

APPLICATIONSApplication forms can be downloaded from the DF’s web site www.dermatologyfoundation.org or obtained by writing: Chairman, Medical & Scientific Committee, Dermatology Foundation, 1560 Sherman Avenue, Evanston IL 60201-4808 (fax: 847-328-0509).

PROCEDURESApplications for funding must be received by the Foundation no later than October 15th each year. All applications are subject to peer review by the Foundation’s Medical and Scientific Committee. Members do not participate in evaluation of applications from institutions with which they are associated or applications in which they have a real or apparent conflict of interest. The following members of the specialty served pro bono as members of the 2004 Medical and Scientific Committee:

Medical and Scientific CommitteeAnita C. Gilliam, M.D., Ph.D., Case Western Reserve University Committee ChairJack L. Arbiser, M.D., Ph.D., Emory UniversityAndrew Blauvelt, M.D., Center for Cancer Research, National Cancer InstituteCraig A. Elmets, M.D., University of Alabama at BirminghamSewon Kang, M.D., M.P.H., University of MichiganMolly Kulesz-Martin, Ph.D., Oregon Health & Science UniversityPui-Yan Kwok, M.D., Ph.D., University of California, San FranciscoSancy A. Leachman, M.D., Ph.D., Huntsman Cancer Institute, Salt Lake City, UTB. Jack Longley, Jr., M.D., University of Wisconsin-MadisonLeonard M. Milstone, M.D., Yale University School of Medicine

Clinical PanelVictoria P. Werth, M.D., Panel Director, University of PennsylvaniaIrwin Braverman, M.D., Yale Medical SchoolMarta Petersen, M.D., University of UtahWarren Piette, M.D., University of Iowa Hospital and Clinics

Dermatologic Surgery PanelTimothy M. Johnson, M.D., Panel Director, University of MichiganDavid J. Leffell, M.D., Yale UniversityStanley J. Miller, M.D., Johns Hopkins UniversityMarcy Neuburg, M.D., MCW Clinic at FroedtertR. Stan Taylor, M.D., University of Texas, SW Medical Center

Medical Dermatology PanelMarta Petersen, M.D., Panel Director, University of UtahIrwin Braverman, M.D., Yale Medical SchoolWarren Piette, M.D., University of Iowa Hospital and Clinics Guy Webster, M.D., Ph.D., Thomas Jefferson University Medical CollegeVictoria P. Werth, M.D., University of Pennsylvania

The Dermatology Foundation has a comprehensive program of research awards designed to enhance the scientific base of both clinical and surgical dermatology. Research must be conducted in the U.S. under the sponsorship of a division or department of dermatology. Physician Scientist Career Development Awards, Medical Dermatology Career Development Awards, Clinical Career Development Awards in Dermatologic Surgery, Clinical Career Development Awards in Health Care Policy and Research Career Development Awards carry annual salary stipends of $55,000 and may be renewed for two additional years. Physician Scientist Career Development Awards are designed to support the academic careers of physician-scientists who are devoted to clinical dermatology. This category aids junior investigators in the transition from fellowship to established investigator. Applicants must have completed training in a U.S. dermatology residency program and be faculty members in a department or division of dermatology throughout the term of the award. Medical Dermatology Career Development Awards are designed to develop future intellectual leaders, educators and clinical scholars in those aspects of dermatology that address severe, systemic dermatologic disease. Applicants must have completed training in a U.S. dermatology residency program and hold junior faculty positions in a department or division of dermatology throughout the term of the award. In addition, there must be strong institutional commitment for the investigators career development for three years and beyond. Clinical Career Development Awards in Dermatologic Surgery are availableto individuals who have completed at least one year post-residency surgical training, hold a junior faculty appointment in a division or department of dermatology and be no more than five years post-residency. The applicant’s mentor and environment are critical considerations for peer reviewers. Health Care Policy Clinical Career Development Awards help establish and develop health care policy careers for dermatologists. Applicants must have completed training in a U.S. dermatology residency program, be faculty members in a department or division of dermatology through the term of the awards and have a formal relationship with an organization with recognized expertise in health policy research. Research Career Development Awards assist junior investigators in the early stages of their careers in the transition from fellowship to investigator. Applicants must have completed a two- to three-year fellowship or postdoctoral training in relevant research and be faculty members in a department or division of dermatology throughout the period of the award. Dermatologist Investigator Research Fellowships provide $30,000 for one-year, postdoctoral support. Applicants must have an M.D., M.D.-Ph.D. or D.O. degree and have completed training in a U.S. dermatology residency program. Research Fellowships provide $30,000 for one year of support for research training on the part of individuals who are M.D.s, Ph.D.s or hold equivalent degrees. The Foundation offers a $30,000, one-year Fellowship in Pediatric Dermatology in conjunction with the American Society of Pediatric Dermatology. Research Grants provide $20,000 for one year to initiate research projects in dermatology and cutaneous biology. Research has to be performed within a department or division of dermatology. Patient Directed Investigation Grants provide $20,000 for one year for studies that have the potential to directly benefit patients. Applicants must have completed training in a U.S. dermatology residency program and be sponsored by a department or division or dermatology. Dermatopathology Research Grants provide $10,000 for one year. Applications are only accepted from dermatologists or

2003 ANNUAL REPORT 23

Page 26: DERMATOLOGY

24 DERMATOLOGY FOUNDATION

2003 Clark W. Finnerud Award

Milwaukee dermatologist Thomas J. Russell, M.D. a “consummate clinician-educator” is the 2003 honoree. After earning his B.S. and then M.D. at Milwaukee’s Marquette University School of Medicine—now the Medical College of Wisconsin (MCW)—and his dermatology residency at the Mayo Clinic in Rochester, MN, Dr. Russell joined the Department of Dermatology at MCW in 1968 as a clinical instructor and established a thriving private practice that is now a group of seven dermatologists. From the start of his career, Dr. Russell demonstrated the scope of his abilities as a dermatologist with his innovative research in the early 1970s documenting the immunogenetics of psoriasis which has paved the way for current advances in the genetics of the disease. Along with this pioneering work, Dr. Russell was instrumental in establishing an independent Department of Dermatology at MCW. As interim chairman, he sustained the department’s vitality and purpose during two extended periods and was chosen by medical school faculty to receive the 2002 Marvin Wagner Preceptor Award for his substantial contributions to MCW as a volunteer faculty member. He has repeatedly earned public honors as a top clinician, and Dr. Russell’s exceptional clinical and teaching strengths have long made his weekly clinics a favorite of residents. Dr. Russell summed-up his philosophy: “In today’s environment of difficult recruitment of full-time faculty, committed clinical dermatologists can provide a crucial role in the education of residents, and at times, the forgotten medical student. We have a responsibility to foster passion among our residents for our profession so that they will continue to function as full-time clinical faculty in the future. To teach is to learn twice, and collectively, we owe a great deal to our residents for what they have taught us.” In introducing Dr. Russell, Dr. Kim B. Yancey, current chairman of the dermatology department at MCW, said “On a national level, the Dermatology Foundation’s Finnerud Award signifies what the local community has known for some time—that Dr. Russell is committed to medical excellence, medical education, and scholarly activities.”

2003 Practitioner of the Year Award

Lenore S. Kakita, M.D., regarded by those who nominated her for this award as “a shining star in dermatology” and “a perfect role model and mentor,” began her career in medicine close to home at UCSF. After interning at Children’s Hospital in Los Angeles, Dr. Kakita completed her dermatology residency in 1971 at UCLA where she has been ever since and maintains an active private practice. Other comments from nominators note that “her patients love her” and call her “a caring and compassionate clinician, a superb communicator, and innovative in her treatment techniques.” Dr. Kakita’s career has been characterized by her willing eagerness to take on challenges to benefit the specialty and patients to whom she is devoted. These challenges have involved important dermatology and medical organizations at the metropolitan, state, regional, national and international levels. As a result of her concern for patient- and healthcare-related issues and her involvement in both California and federal legislation, she has played a meaningful role in the enactment of policies favorable to dermatology, and improved reimbursement and overall gains in respect for the practice of dermatology. At the heart of it all said Dr. Kakita “…I enjoy my wonderful patients—many of whom have family that spans three or four generations. Their warmth, trust and friendships have been extremely gratifying. This is why I have been an active practitioner in organized medicine and organized dermatology which, in turn, has allowed me to focus on providing quality of care for my patients, to stand-up for the practitioners and to support women and minorities.” In introducing Dr. Kakita, friend and long-time colleague, Dr. Wilma F. Bergfeld, reiterated this career focus by incorporating a quote from Dr. Kakita: “ ‘My goal has been to maintain the rights of practitioners of dermatology and provide quality care to my patients.’ Lenore, you did it! Thank you.”

The Clark W. Finnerud and The Practitioner of the Year Awards were created in the 1970’s to honor, respectively, a dermatologist whose

contributions as a clinical educator are exemplary and a dermatologist who exemplifies the best of clinical service to individual patients.

Each Award is recognized throughout the specialty as career achievement honors.

Dr. Russell Dr. Kakita

Honoring Excellence

Page 27: DERMATOLOGY

2003 ANNUAL REPORT 25

Peer Recognition This paramount award from the Dermatology Foundation

was established to recognize the highest levels of dedicated

and insightful leadership and service to the specialty.

Distinguished Service Award

For just the fourth time since its founding in 1964, the Dermatology Foundation presented its highest honor—the Distinguished Service Award-—to Eugene J. Van Scott, M.D. for his unique leadership and service to dermatology. During his illustrious career, Dr. Van Scott was a teacher, a researcher, a leader and an entrepreneur in the development of the specialty as it is today. His leadership benefited many organizations, but perhaps most profoundly, the Dermatology Foundation. Dr. Van Scott was one of the 10 visionary founders and early trustees of the Dermatology Foundation along with the late Irvin H. Blank, Ph.D. and Thomas B. Fitzpatrick, M.D., Ph.D. who were the first recipients of this high honor. The Dermatology Foundation’s growth from a new idea to a membership in the thousands, a budget in the millions, substantial industry support, and a research agenda rich in breadth and depth owes this success in no small measure to Dr. Van Scott. As he remarked during the presentation of the award, in the early 1960’s “as NIH funding became more competitive..we needed this driving force in research to make sure that young researchers got funded. None of us at that time conceived what would happen to this Foundation… (which) has become an institute unto itself..an institute for leadership in research and the direction of dermatology much as the Academy is the institute for leadership and direction in the field of teaching. The mission of the Dermatology Foundation today is seeding the foundations for dermatology tomorrow.” Dr. Van Scott has been a member of the specialty for more than 50 years since his residency at the University of Chicago Clinics in the late 1940’s. After a year’s affiliation with the University of Pennsylvania, he headed the dermatology program at the National Cancer Institute (NCI) for the next 15 years. He was also Scientific Director for General Laboratories and Clinics at the NCI in the mid-60’s. Dr. Van Scott spent the next two decades in academic dermatology as a professor at Temple University and concluded his academic career at Hahnemann University. His publication history spans his professional career, and Dr. Van Scott has been honored many times over by the specialty with prestigious awards. As a man of action and an eminent spokesman on many fronts, Dr. Van Scott served several terms on the AAD Board of Directors and has played formative roles in the National Psoriasis Foundation and the

Dr. Van Scott

Society for Investigative Dermatology as well as holding important advisory positions on a number of FDA committees and the US Pharmacopoeia. In addition, he was part of a team whose scientific work, spanning more than 10 years, discovered the benefits of alpha hydroxyl acids and was co-founder of the research-based dermatological company, NeoStrata Company, Inc.

The Lifetime Career Educator Award was created by the

Foundation’s Trustees in 1999 as a means of honoring

those full-time academicians who have devoted their

careers to educating dermatology residents and fellows.

2003 Lifetime Career Educator Award

Harley A. Haynes, M.D., has a long and distinguished track record in teaching and is considered the “Dean of Dermatology Education” throughout the Harvard system. In 1970 he joined the dermatology faculty at Harvard, and by 1987 had become part of what is now the Harvard-MIT Division of Health Sciences and Technology. Dr. Haynes’ enormous agenda of clinical activities has been matched only by his teaching commitments and impact. His colleagues share their praise referring to him as “a very powerful force in teaching about skin and dermatology, with great clinical judgment…the complete compassionate physician… admired by students, residents, and faculty.” Given the enthusiasm of his students, Harvard Medical School (HMS) has awarded him the Faculty Award for Excellence in Teaching (1985 and 1987), and in 2000, the Daniel D. Federman Outstanding Clinical Educator. In addition, the Department of Dermatology named him the 1997 Sam Moschella Teaching Scholar in recognition of his renown as a teacher, mentor, advisor, and role model to his students. Dr. Haynes is currently Professor of Dermatology at HMS, Vice Chair of the Department of Dermatology at Brigham and Women’s Hospital and Associate Chief, Dermatology Service, Boston VA Healthcare System.

Outside his institution, he has helped shape the dermatology curricula at all levels and has influenced the training of all dermatology residents: he regularly conducts education sessions at annual AAD meetings, has published almost 100 articles and a significant number of teaching materials, and participates in national education committees. Echoing the scope of Dr. Haynes’ influence as an educator was summed-up by Dr. John A. Parrish, chair of HMS department of dermatology, in his introduction of Dr. Haynes: “Through his students, now practicing and teaching throughout the United States, Harley has impacted our specialty well beyond his efforts in Boston.” As he accepted his award, Dr. Haynes expressed it this way: “I hope some of the younger people will say ‘Yes! I can do that….and do it!”

Dr. Haynes

Page 28: DERMATOLOGY

Education for Today’s PractitionerThe Foundation’s Annual Colloquium on Clinical Dermatology and

its publications provide members of the specialty with current,

clinically-relevant knowledge and are an important adjunct to

the continuing education offerings of other organizations.

2003 COLLOQUIUM ON CLINICAL DERMATOLOGYThe Colloquium is held annually in cooperation with the Association of Professors of Dermatology. The Trustees thank Dr. Barbara A. Gilchrest for serving as Program Chairman for the 2003 Colloquium and Dr. Paul R. Bergstresser, President of the Association of Professors of Dermatology, for his assistance in providing the following faculty members: John C. Ansel, M.D., David R. Bickers, M.D., Jean Bolognia, M.D., Vincent Falanga, M.D., Richard A. Johnson, M.D., Gerald G. Krueger, M.D., David A. Norris, M.D., Arthur R. Rhodes, M.D., M.P.H., Leslie Robinson-Bostom, M.D., Alain H. Rook, M.D., Daniel N. Sauder, M.D., FRCP(C) FACP, and Clifton R. White, Jr., M.D. The Colloquium was underwritten by the following corporate sponsors, and the Trustees express their appreciation: Allergan Skin Care, Berlex Laboratories, Inc., Biogen, Inc., Connetics Corporation, Dermik Laboratories, Inc., Enhanced Derm Technologies, Ferndale Laboratories, Inc., Fujisawa Healthcare, Inc., Galderma Laboratories, L.P., ICN Pharmaceuticals, Medicis, The Dermatology Company®, Merz Pharmaceuticals, Ortho Neutrogena, Roche Laboratories, Inc., SkinMedia, Inc., Unilever Home & Personal Care—USA The Colloquium format of roundtables, selected scientific presentations and opportunities for one on one consultations and conversations with faculty members make the annual event both popular with and relevant to the concerns of practitioners. Colloquium attendees consistently rank both the content and format as the best, most “hands-on” program available anywhere within the specialty. Among topics covered at the 2003 Colloquium were: Disorders of Pigmentation, Skin Manifestations of AIDS and Its Therapy, Wound Management, What Can Be Done for CTLC and New Immunomodulators for Psoriasis. Each attendee receives 14 hours of American Academy of Dermatology Category 1 credit, which may be used toward the Continuing Medical Education Award of the AAD.

Physician Publications

Dermatology Focus is edited by Ponciano D. Cruz, Jr., M.D. and provides basic technological information and current scientific research of relevance to both clinicians and academicians. It is sent, at no charge and on a quarterly basis, to all members of the specialty as an educational service of the Foundation.

Progress in Dermatology is published quarterly and distributed exclusively to members of the Foundation. Alan H. Moshell, M.D. edits the journal, which provides in-depth coverage of clinically relevant topics as well as basic scientific advances affecting all of dermatology.

Pathways to the Future is available at no charge to all members of the specialty as part of the Foundation’s Research Futures Fund. Both the Fund and Pathways provide physicians with long-term estate planning information and give them an opportunity to make a lasting gift to the specialty through planned and deferred-giving mechanisms.

26 DERMATOLOGY FOUNDATION

Page 29: DERMATOLOGY

2003 ANNUAL REPORT 27

03Other Contributions from the Specialty

Contributions at all levels are critical to the growth of the specialty and increase resources for research.

The Trustees express appreciation to the following colleagues who joined the 2003 Scientific Society with

contributions of $500 to $999. We hope their annual giving commitment will grow with their careers.

Ashley Wallace Adams, M.D.

Carrie D. Alspaugh, M.D.

Dina N. Anderson, M.D.

Melanie L. Appell, M.D.

Harvey Arbesman, M.D.

Eva M. Balash, M.D.

Sharon H. Barrett, M.D.

Lisa A. Beck, M.D.

James H. Beckett, M.D.

Wilma F. Bergfeld, M.D.

Evelina A. Bernardino, M.D.

Julie K. Billings, M.D.

Michael E. Borok, M.D.

J. Christopher Braker, M.D.

Mitchell L. Bressack, M.D.

Ted Brezel, M.D.

Roger H. Brodkin, M.D.

Nancy Bruckner, M.D.

Patrick H. Burkhart, M.D.

Carolyn Bialecki Carroll, M.D.

Jean Carruthers, M.D.

Karen L. Chapel, M.D.

Juliana Y.H. Chyu, M.D.

Lucius P. Cook, M.D.

David Cooper, M.D., Ph.D.

Thomas A. Cortese, Jr., M.D., Ph.D.

Jeffrey J. Crowley, M.D.

Lauren Avrum Daman, M.D.

Thomas L. Fisher, Sr., M.D.

James M. Flood, M.D.

Mona Salem Foad, M.D.

Pamela L. Foresman, M.D.

Gerald A. Gellin, M.D.

Gerald C. Gladstone, M.D.

Earl G. Gross, M.D.

Peter S. Halperin, M.D.

Katherine R. Hamlet, M.D.

Julie C. Harper, M.D.

A. Howland Hartley, M.D.

Christina A. Herrick, M.D., Ph.D.

J. Mark Jackson, M.D.

Joseph D. Jensen, M.D.

Daniel B. Jones, M.D.

Robert E. Kalb, M.D.

Bryna Kane, M.D.

Sherri K. Kaplan, M.D.

Jeffrey E. Karaban, M.D.

Kevin B. Karikomi, D.O.

Lisa Kates, M.D.

Ronald A. Katz, M.D.

Francisco Kerdel, M.D.

John L. Kestel, Jr., M.D.

Roger S. Knutsen, M.D.

Randal C. Kumm, M.D.

Kathrin Freitag Laing, M.D.

Joyce A. Lender, M.D.

Dennis L. May, M.D.

Michael G. McCauley, M.D.

Gwendellyn L. McLean, M.D.

Alvin H. Meyer, Jr., M.D.

Lawrence B. Meyerson, M.D.

Samuel L. Moschella, M.D.

Peter J. Neidenbach, M.D.

Catherine A. Nordby, M.D.

Eric G. Olson, M.D.

Margaret E. Parsons, M.D.

Carolyn J. Pass, M.D.

Alyson C. Penstein, M.D.

Thomas C. Peterson, M.D.

Robert B. Pittelkow, M.D.

Ronald L. Pitts, M.D.

Dale R. Pokorney, M.D.

Ian Pravda, M.D.

Michael Radowsky, M.D.

Daisy Pelayo Ramos, M.D.

Ronnie D. Rasberry, M.D.

Don L. Reese, M.D.

Philip L. Repetto, Jr., M.D.

Barbara E. Resnick, M.D.

Hobart K. Richey, M.D.

Darrell S. Rigel, M.D.

David S. Rubenstein, M.D., Ph.D.

William H. Saye, Jr., M.D.

Richard S. Schwartz, M.D.

Patricia L. Seal, M.D.

Richard H. Shereff, M.D.

Donald W. Smith, M.D.

Marc J. Sorkin, M.D.

Elizabeth Tanzi, M.D.

James S. Taylor, M.D.

Randy B. Ugent, M.D.

John H. Uhlemann, M.D.

Mark C. Valentine, M.D.

Val Pierre Vallat, M.D.

Alan I. Westheim, M.D.

Gregory P. Wittenberg, M.D.

Barbara A. Wolf, Ph.D.

Nancy S. Wolfin, M.D.

Winona Y. Wong, M.D., Ph.D.

James A. Zalla, M.D.

Scientific SocietyMembers

Page 30: DERMATOLOGY

28 DERMATOLOGY FOUNDATION

Report of Independent Public Accountants We have audited the accompanying Statement of Financial

Position of Dermatology Foundation as of December 31,

2003 and the related Statements of Activities and Cash

Flows for the year then ended. The statements are the

responsibility of the Foundation’s management. Our

responsibility is to express an opinion on these financial

statements based on our audit. We conducted our audit in

accordance with U.S. generally accepted auditing standards.

Those standards require that we plan and perform the audit

to obtain reasonable assurance about whether the financial

statements are free of material misstatement. An audit

includes examining, on a test basis, evidence supporting

the amounts and disclosures in the financial statements.

An audit also includes assessing the accounting principles

used and significant estimates made by management, as well

as evaluating the overall financial statement presentation.

We believe that our audit provides a reasonable basis for

our opinion. In our opinion, the financial statements

referred to above present fairly, in all material respects,

the financial position of Dermatology Foundation as of

December 31, 2003 and the results of its operations and

its cash flows for the 12 months then ended in conformity

with U.S. generally accepted accounting principles.

Respectfully submitted,

Walter J. Newton & Co., Certified Public Accountants 30 East Adams Street Suite 440 Chicago, Illinois 60603-5610 January 27, 2004

Statement of ActivitiesFor the year ended December 31, 2003

REVENUE Membership Dues $ 1,551,359 Contributions 2,310,797 Investment Income 44,995 $ 481,736 Registration Fees 32,100 Administrative Fees 2,943 — Restricted Programs 70,000 Scientific Publications 130,440 Dues Transferred to Endowment Fund 662,066

Total Revenue $ 4,142,633 $ 1,143,802

EXPENSES Research Awards Expended $ 1,915,850 2,385 Membership/Program Services 829,191 Administrative Support Services 163,918 Winter Colloquium 103,458 Clinical Symposia 560,000 Depreciation 80,537 Administrative Fees — 2,943 Credit Card Fees 17,830 Restricted Programs 146,695

Scientific Publications 120,235

Total Expenses $ 3,973,714 $5,328

Increase in Net Assets $ 168,919 $ 1,138,474

NET ASSETS January 1, 2003 $ 4,453,404 $ 4,402,278 December 31, 2003 $ 4,622,323 $ 5,540,752

Statement of Financial Position December 31, 2003

ASSETS Current Assets: Cash Investments & Restricted Funds $ 10,342,843 Deposits and Receivables 1,275,432

Total Current Assets $ 11,618,275

Fixed Assets: Furniture and Fixtures & Leasehold Improvements 563,444 Accumulated Depreciation (478,433)

Net Book Value 85,010

Total Assets $ 11,703,286

LIABILITIES & NET ASSETS Current Liabilities: Accounts Payable $ 409,423 Research Commitments Not Yet Expended 1,130,789

Total Current Liabilities 1,540,212

Net Assets 10,163,074

Total Liabilities & Net Assets $11,703,286

General FundRestricted

Special Funds

Page 31: DERMATOLOGY

2003 TRUSTEESTina S. Alster, M.D.Rex A. Amonette, M.D.Hilary E. Baldwin, M.D.Rodney S.W. Basler, M.D.Jean L. Bolognia, M.D.Marc D. Brown, M.D.Alastair Carruthers, M.D.Roger I. Ceilley, M.D.Lynn A. Cornelius, M.D.Richard L. Edelson, M.D.Lawrence F. Eichenfield, M.D.James O. Ertle, M.D.Lisa A. Garner, M.D.Anita C. Gilliam, M.D., Ph.D.Victoria L. Holloway, M.D.Timothy M. Johnson, M.D.Gerald G. Krueger, M.D.David J. Leffell, M.D.James J. Leyden, M.D.Henry W. Lim, M.D.Stephen H. Mandy, M.D.Mary C. Martini, M.D.Seth L. Matarasso, M.D.Marcy Neuburg, M.D.Glenn A. OclassenPeter B. Odland, M.D.Elise Olsen, M.D.Amy S. Paller, M.D.William S. Sawchuk, M.D.Richard K. Scher, M.D.Steven K. Shama, M.D.Neil A. Swanson, M.D.Michael D. Tharp, M.D.Jouni J. Uitto, M.D., Ph.D.John J. Voorhees, M.D.Patricia S. Walker, M.D., Ph.D.Susan H. Weinkle, M.D.Bruce U. Wintroub, M.D.

DERMATOLOGY FOUNDATION

2003 EXECUTIVE COMMITTEE

Jouni J. Uitto, M.D., Ph.D. Chairman, Board of Trustees

Bruce U. Wintroub, M.D. President

Richard L. Edelson, M.D. Vice President

Michael D. Tharp, M.D. Secretary–Treasurer

Neil A. Swanson, M.D.

Assistant Secretary-Treasurer

MEMBERS AT LARGEAnita C. Gilliam, M.D., Ph.D. Gerald G. Krueger, M.D. James J. Leyden, M.D. Glenn A. Oclassen John J. Voorhees, M.D.

EXECUTIVE DIRECTORSandra Rahn Benz

GENERAL COUNSELRobert M. Grossman

Gardner, Carton & Douglas

Page 32: DERMATOLOGY

Non-Profit OrganizationU.S. Postage PAIDPermit No. 236Melrose Park, Illinois

Dermatology Foundation1560 Sherman AvenueEvanston, Illinois 60201-4808

Tel: 847.328.2256Fax: 847.328.0509E-mail: [email protected]